{"meta":{"query_hash":"a001d20b2d0f","filters":{"venue":"mAbs"},"cohort_total":85,"direct_labels_cover":0,"predictions_cover":85,"exported":85,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a001d20b2d0f","api":"https://metacan.xera.ac/api/v1/cohort?venue=mAbs"},"results":[{"id":"W1502370099","doi":"10.4161/mabs.28831","title":"Antibody biosimilars: Fears or opportunities?","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Genentech","keywords":"Biosimilar; Pharmacovigilance; Context (archaeology); Agency (philosophy); Session (web analytics); European union; Business; Quality (philosophy); Competitor analysis; General partnership; Marketing; Public relations; Medicine; Political science; Finance; Pharmacology; International trade; Advertising; Sociology","score_opus":0.07391033678415444,"score_gpt":0.3336394204290503,"score_spread":0.2597290836448959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502370099","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32447985,0.008925414,0.05402748,0.1034416,0.014893528,0.0019617865,0.0005263486,0.0021571175,0.4895869],"genre_scores_gemma":[0.914534,0.0004553213,0.0041952943,0.017326677,0.000205189,0.000014371844,0.00018691734,0.000047124635,0.06303516],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989254,0.00023779369,0.00021414961,0.0002479175,0.00003243894,0.0003422856],"domain_scores_gemma":[0.9993653,0.0001856636,0.000058603244,0.0003011751,0.00004821019,0.000040996132],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004710082,0.00015092109,0.00025328572,0.000074733885,0.00012336575,0.000022203541,0.00021177038,0.00026448048,0.0049572038],"category_scores_gemma":[0.00019633902,0.00010066345,0.000090093694,0.00011160199,0.00024518912,0.000046973608,0.000087647815,0.00020438955,0.00040419478],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055324845,0.00039034913,0.0031625405,0.000095694144,0.00038264276,0.000055991783,0.00017768674,5.8984017e-7,0.62935966,0.02128345,0.15253103,0.19200708],"study_design_scores_gemma":[0.00062456744,0.00029029918,0.0027175632,0.00002891279,0.00004759314,0.000051971743,0.00012582402,0.000021092841,0.02406858,0.00065354124,0.97115755,0.00021248896],"about_ca_topic_score_codex":0.000009641369,"about_ca_topic_score_gemma":0.000006411221,"teacher_disagreement_score":0.8186265,"about_ca_system_score_codex":0.000012035214,"about_ca_system_score_gemma":0.00002930202,"threshold_uncertainty_score":0.9959524},"labels":[],"label_agreement":null},{"id":"W1592578892","doi":"10.1080/19420862.2015.1029215","title":"Production of α2,6-sialylated IgG1 in CHO cells","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Manitoba; National Research Council Canada","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Chinese hamster ovary cell; Glycan; Sialic acid; Sialyltransferase; Chemistry; Antibody; SIGLEC; Galactosyltransferase; Mutant; Biochemistry; Glycosylation; N-Acetylneuraminic acid; Fragment crystallizable region; Molecular biology; Biology; Glycoprotein; Gene; Enzyme; Receptor; Immunology","score_opus":0.05900827417885001,"score_gpt":0.3330740630077162,"score_spread":0.2740657888288662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1592578892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875112,0.00022913677,0.000002920506,0.0028870648,0.00024222018,0.00025365053,0.0000024263575,0.000013562947,0.008857826],"genre_scores_gemma":[0.9836419,0.000053248852,0.00018335436,0.000064197186,0.00017167916,0.000007664379,0.000015927526,0.0000069902444,0.015855005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992747,0.000028029439,0.00016131844,0.00012722745,0.00026065254,0.00014810878],"domain_scores_gemma":[0.99960685,0.00001312908,0.000028203754,0.00013230482,0.00012223936,0.00009726683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025058223,0.000057492536,0.00015520235,0.00010800885,0.000010439091,0.0000029035493,0.000045676767,0.00004296583,0.00011981766],"category_scores_gemma":[0.00008730985,0.000043950382,0.00003176797,0.00022479023,0.0000516317,0.00003212165,0.000030124464,0.0001248422,0.00012575726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039624856,0.001093186,0.15718506,0.00065596483,0.0001001049,0.0002027304,0.0025058384,0.00016245316,0.71833116,0.0009581484,0.06425251,0.05059034],"study_design_scores_gemma":[0.0031239954,0.00083596475,0.16887191,0.0002637201,0.000032590757,0.00008732986,0.0003906852,0.0007056063,0.60374427,0.0008943942,0.22082147,0.00022806904],"about_ca_topic_score_codex":0.0004579097,"about_ca_topic_score_gemma":0.000035733752,"teacher_disagreement_score":0.15656896,"about_ca_system_score_codex":0.000033596218,"about_ca_system_score_gemma":0.00008044358,"threshold_uncertainty_score":0.17922446},"labels":[],"label_agreement":null},{"id":"W1607323233","doi":"10.4161/mabs.3.5.17485","title":"2nd Charles Richet et Jules Héricourt Workshop","year":2011,"lang":"fr","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Medicine","score_opus":0.11858933786159151,"score_gpt":0.3531446805968117,"score_spread":0.2345553427352202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1607323233","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29631042,0.19643775,0.00040984293,0.061160844,0.004693752,0.0007325523,0.00023067677,0.00014750268,0.43987668],"genre_scores_gemma":[0.3567604,0.022886558,0.0028932667,0.003123071,0.002779674,0.000039922186,0.00009511486,0.00007949033,0.6113425],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975081,0.00019099939,0.00036912205,0.0004234715,0.00057125854,0.000937017],"domain_scores_gemma":[0.9985757,0.00027158557,0.00008116598,0.00040948336,0.00016289024,0.0004991745],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006566103,0.00031615503,0.0004383554,0.00016472909,0.0001547386,0.00004653529,0.0003079806,0.00026263678,0.016618012],"category_scores_gemma":[0.00021503284,0.0002626444,0.00021852131,0.00031376415,0.00042110973,0.0001561792,0.000263504,0.00073155627,0.0056308648],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017127979,0.0021817167,0.067998804,0.0017157492,0.0008434307,0.0027623554,0.010352019,0.00000415037,0.002849635,0.1409649,0.47153777,0.29707667],"study_design_scores_gemma":[0.0008179736,0.0003487104,0.093099356,0.0007745532,0.00012920999,0.00019805414,0.0009273146,0.0002601211,0.0019535855,0.0032088775,0.8979171,0.00036515424],"about_ca_topic_score_codex":0.0017400169,"about_ca_topic_score_gemma":0.00023531236,"teacher_disagreement_score":0.42637932,"about_ca_system_score_codex":0.00007568164,"about_ca_system_score_gemma":0.00017993977,"threshold_uncertainty_score":0.9999826},"labels":[],"label_agreement":null},{"id":"W1678266201","doi":"10.4161/19420862.2014.971627","title":"Antibody engineering and therapeutics conference","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Burnaby Hospital; Simon Fraser University","funders":"","keywords":"Context (archaeology); Library science; Engineering ethics; Management; Political science; Environmental ethics; Engineering; History; Computer science; Philosophy","score_opus":0.029211221674520962,"score_gpt":0.3199802806767383,"score_spread":0.29076905900221733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1678266201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862576,0.00033052915,0.00168552,0.002715579,0.00005258053,0.000075223295,0.000002025045,0.00003434656,0.008846593],"genre_scores_gemma":[0.9964841,0.00019592958,0.00066529517,0.00045148385,0.000109005305,0.0000017690147,0.00001342343,0.0000071303693,0.0020718528],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995773,0.000008924679,0.00006429282,0.00009395148,0.00011949584,0.00013602182],"domain_scores_gemma":[0.99974483,0.00004596983,0.000008416772,0.000086386935,0.00003877774,0.00007559193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008292393,0.000059755494,0.00010371087,0.000033199234,0.000029244247,0.000015041078,0.000032912125,0.000029841138,0.00009226991],"category_scores_gemma":[0.000019906816,0.000044141096,0.000019407405,0.000040210074,0.000035894886,0.000017643784,0.000031605607,0.00010197382,0.000042554544],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002156629,0.000094675685,0.11473229,0.0005480205,0.00012544903,0.000045178404,0.00047499363,0.0000074113996,0.7489149,0.043192048,0.00027047133,0.09137891],"study_design_scores_gemma":[0.0010147116,0.00046904178,0.37523416,0.00016201334,0.000042018422,0.00016476013,0.00004339001,0.048334535,0.009181093,0.00062108034,0.56451064,0.00022255178],"about_ca_topic_score_codex":0.000021157499,"about_ca_topic_score_gemma":0.0000012584701,"teacher_disagreement_score":0.7397338,"about_ca_system_score_codex":0.0000042621896,"about_ca_system_score_gemma":0.000011553718,"threshold_uncertainty_score":0.18000217},"labels":[],"label_agreement":null},{"id":"W1774891022","doi":"10.1080/19420862.2016.1227665","title":"Antibody Engineering &amp; Therapeutics 2016: The Antibody Society's annual meeting, December 11–15, 2016, San Diego, CA","year":2016,"lang":"en","type":"article","venue":"mAbs","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada); Simon Fraser University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Bispecific antibody; Daratumumab; Antibody; Medicine; Session (web analytics); Immunology; Computer science; Monoclonal antibody; World Wide Web","score_opus":0.02193367853374353,"score_gpt":0.32755611131672957,"score_spread":0.30562243278298606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1774891022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642639,0.0048751733,0.006000638,0.00865627,0.0009941784,0.0014078831,0.00013543387,0.00043866702,0.01322784],"genre_scores_gemma":[0.8202749,0.0037227615,0.0016177701,0.0022222262,0.002420424,0.00006826315,0.00020494386,0.00031993553,0.16914876],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974677,0.000099688674,0.0003740683,0.00046381252,0.0007453866,0.00084933924],"domain_scores_gemma":[0.99800885,0.00045137835,0.000094210765,0.0009621047,0.00026535246,0.00021811151],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008883706,0.00034493537,0.0004010303,0.00009508188,0.00019890018,0.000063647036,0.00037484092,0.00021316137,0.007981573],"category_scores_gemma":[0.000117332864,0.00019008607,0.0003336821,0.00030344987,0.0002302754,0.00013495622,0.00019803767,0.00039911567,0.000766855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013190418,0.00011780943,0.014428326,0.000064865395,0.00032989436,0.000020937,0.0012054367,0.000008747338,0.8908487,0.0000579001,0.0848322,0.007953256],"study_design_scores_gemma":[0.0019280548,0.00016641928,0.01346128,0.00034504893,0.00011139296,0.000081206264,0.00027673476,0.00031699598,0.01198075,0.00004675721,0.97093827,0.00034708294],"about_ca_topic_score_codex":0.00020210238,"about_ca_topic_score_gemma":0.00015668983,"teacher_disagreement_score":0.8861061,"about_ca_system_score_codex":0.00014727695,"about_ca_system_score_gemma":0.00019618124,"threshold_uncertainty_score":0.9929253},"labels":[],"label_agreement":null},{"id":"W1821389859","doi":"10.1080/19420862.2015.1038447","title":"Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"IC Design Education Center; Biogen","keywords":"Progressive multifocal leukoencephalopathy; Biology; Virology; JC virus; Sialic acid; Antibody; Capsid; Immunology; Virus; Genetics","score_opus":0.032843655487915846,"score_gpt":0.28395477115899675,"score_spread":0.2511111156710809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1821389859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98350644,0.01349136,0.000020682048,0.0007013319,0.00012170105,0.0008007818,0.000028752975,0.00010306952,0.0012258573],"genre_scores_gemma":[0.99784774,0.00012507848,0.0013303917,0.00007821662,0.000102583246,0.00010682452,0.000031758893,0.00003143438,0.00034596463],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998547,0.00008242651,0.00034593762,0.00038520774,0.0002652756,0.00037411062],"domain_scores_gemma":[0.9992202,0.000044585322,0.00009798421,0.00021551219,0.00010401628,0.00031770195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019197549,0.00021744314,0.00032213816,0.00023255992,0.00010909458,0.000053718042,0.0000673085,0.00012257598,0.000041037216],"category_scores_gemma":[0.00026502623,0.000173062,0.00006863042,0.00019201216,0.00031998876,0.00017671484,0.00006440485,0.00025823875,0.00009054211],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056721102,0.0055064093,0.266587,0.0012738822,0.0005880349,0.016841263,0.032636568,0.00019985277,0.2743881,0.0035588713,0.0033854153,0.3893625],"study_design_scores_gemma":[0.04126381,0.005457004,0.67719775,0.015414646,0.0012057807,0.004637035,0.039499108,0.0104197785,0.17312112,0.016299147,0.01112388,0.004360921],"about_ca_topic_score_codex":0.00026058248,"about_ca_topic_score_gemma":0.000034428795,"teacher_disagreement_score":0.4106108,"about_ca_system_score_codex":0.00010864679,"about_ca_system_score_gemma":0.00015812472,"threshold_uncertainty_score":0.7057263},"labels":[],"label_agreement":null},{"id":"W1827791620","doi":"10.1080/19420862.2015.1073429","title":"Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab)","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Adalimumab; Monoclonal antibody; Glycosylation; Glycoprotein; Computational biology; Antibody; Tumor necrosis factor alpha; Chemistry; Computer science; Biochemistry; Biology; Immunology","score_opus":0.1799356416068312,"score_gpt":0.4326253722709773,"score_spread":0.25268973066414613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1827791620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97158504,0.004063025,0.0007625719,0.018184483,0.00028258783,0.000935892,0.00031978218,0.00005177698,0.003814875],"genre_scores_gemma":[0.9924588,0.00013905978,0.00084976666,0.00054810115,0.00023996139,0.000036100188,0.00022855245,0.000019200135,0.0054804455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998288,0.00008286065,0.00046381907,0.00023260065,0.0005811719,0.00035156898],"domain_scores_gemma":[0.9978256,0.00074195646,0.00012388908,0.0003613993,0.0007347062,0.00021244548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009726609,0.00015756051,0.00042147725,0.00006534507,0.00013711223,0.000016904602,0.00020324514,0.00009216886,0.00016497752],"category_scores_gemma":[0.0006916506,0.000094773706,0.00022571429,0.00021650436,0.00031183194,0.00004779062,0.00010314455,0.0001885662,0.0000504112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023480866,0.002084109,0.49166322,0.002503795,0.0023550093,0.00015242946,0.0021931315,0.00007301372,0.22114135,0.108286165,0.11372708,0.032339837],"study_design_scores_gemma":[0.01074512,0.0028617994,0.4657642,0.00028035513,0.00040187646,0.00021536033,0.0015661065,0.0041232347,0.04708447,0.008966582,0.4573569,0.0006339981],"about_ca_topic_score_codex":0.0008832352,"about_ca_topic_score_gemma":0.00004067132,"teacher_disagreement_score":0.34362984,"about_ca_system_score_codex":0.00004139475,"about_ca_system_score_gemma":0.00030440628,"threshold_uncertainty_score":0.38647595},"labels":[],"label_agreement":null},{"id":"W1865824976","doi":"10.1080/19420862.2015.1069454","title":"Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Protein purification and stability","field":"Biochemistry, Genetics and Molecular Biology","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Quality by Design; Orbitrap; Critical quality attributes; Computer science; Process analytical technology; Quality (philosophy); Process (computing); Identification (biology); Mass spectrometry; Pharmaceutical manufacturing; Biochemical engineering; Process engineering; Chromatography; Data mining; Chemistry; Work in process; Engineering; Pharmacology; Medicine","score_opus":0.10801251208153193,"score_gpt":0.37258677765215725,"score_spread":0.26457426557062536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1865824976","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43824962,0.000082445564,0.56129074,0.000038413247,0.000015372236,0.0001919049,0.0001243592,0.0000028415125,0.000004290708],"genre_scores_gemma":[0.6085869,0.0000029175187,0.39119688,0.000015992151,0.0000059586687,0.000023665085,0.00015658155,0.000002422924,0.0000086871205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993442,0.00010288244,0.00027424042,0.00015454466,0.000051767984,0.00007232481],"domain_scores_gemma":[0.99921983,0.0000721198,0.00020302416,0.00010511176,0.00036576545,0.000034152657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008996643,0.00006018424,0.0001377604,0.00002229706,0.000028449604,0.0000038288294,0.000047788184,0.000060471553,8.89356e-7],"category_scores_gemma":[0.0018256273,0.00005320561,0.000022062597,0.00006779146,0.00004201216,0.0000029801806,0.000018082692,0.000020244104,1.5803096e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010947192,0.000053564385,0.01945291,0.00005564934,0.00002274863,2.0433463e-8,0.00011349786,0.0000015049002,0.9781014,0.00042169148,0.0000011461179,0.0016664313],"study_design_scores_gemma":[0.0013005541,0.0002830922,0.24269764,0.000011396514,0.000011530009,6.239528e-7,0.00021706893,0.0006803608,0.754049,0.00022273237,0.0004236183,0.00010238216],"about_ca_topic_score_codex":0.0000050820677,"about_ca_topic_score_gemma":0.0000037000273,"teacher_disagreement_score":0.22405237,"about_ca_system_score_codex":0.000011005582,"about_ca_system_score_gemma":0.00006310011,"threshold_uncertainty_score":0.21855782},"labels":[],"label_agreement":null},{"id":"W1912738970","doi":"10.1080/19420862.2015.1022692","title":"An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Research and Development; University of Victoria","keywords":"Antibody-dependent cell-mediated cytotoxicity; Cytokine; Monoclonal antibody; Immune system; Biology; Antibody; Effector; Macrophage; Cytotoxic T cell; Cytotoxicity; Immunology; Opsonin; Cell biology; In vitro; Biochemistry","score_opus":0.047627353450073365,"score_gpt":0.30848329410888936,"score_spread":0.260855940658816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1912738970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98198575,0.0005788362,0.012131568,0.00027563662,0.00023376943,0.00028277715,0.000028272896,0.00017708694,0.0043062815],"genre_scores_gemma":[0.9907373,0.00008806664,0.004200714,0.000097060736,0.0005481075,0.000022227827,0.00028024585,0.000051343555,0.0039749225],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983173,0.000034030512,0.00022245677,0.00038814542,0.000576362,0.00046170285],"domain_scores_gemma":[0.99885714,0.000029005698,0.000045645807,0.00037918455,0.00012829447,0.00056070735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003077369,0.00022670126,0.00030634835,0.00017674582,0.00011686997,0.00006132334,0.00014791747,0.000090343376,0.00007329769],"category_scores_gemma":[0.0000332606,0.00018456911,0.00009229465,0.00017037134,0.00004162931,0.00017323137,0.00009708296,0.00036521166,0.00014427792],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021298693,0.001421891,0.25716788,0.0012791908,0.00027983292,0.00058529264,0.0019979966,0.04275724,0.68384606,0.00032192798,0.0011136897,0.007099142],"study_design_scores_gemma":[0.0044420646,0.001742974,0.050243463,0.00035239212,0.00021705027,0.00083609915,0.0018318361,0.8388576,0.074721925,0.0000919719,0.02558318,0.0010794619],"about_ca_topic_score_codex":0.00027401053,"about_ca_topic_score_gemma":0.0000034891216,"teacher_disagreement_score":0.7961003,"about_ca_system_score_codex":0.00007897973,"about_ca_system_score_gemma":0.00007024784,"threshold_uncertainty_score":0.752651},"labels":[],"label_agreement":null},{"id":"W1960235104","doi":"10.1080/19420862.2015.1016695","title":"Monoclonal antibodies specific to human Δ42PD1: A novel immunoregulator potentially involved in HIV-1 and tumor pathogenesis","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Monoclonal antibody; Pathogenesis; Biology; CD14; Peripheral blood mononuclear cell; Immune system; Antibody; Immunology; Flow cytometry; CD8; Cancer research; In vitro","score_opus":0.02764033238938729,"score_gpt":0.23940149816229128,"score_spread":0.211761165772904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960235104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508387,0.0016468539,0.00037496167,0.00033225634,0.0016286223,0.00019072625,0.000010973854,0.00005144738,0.0006803079],"genre_scores_gemma":[0.99204224,0.0000224223,0.00038002606,0.00028761127,0.00005199015,0.000019251976,0.00013832936,0.00001881985,0.0070392946],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990614,0.00006890168,0.0002952013,0.00028448523,0.000039223163,0.0002507727],"domain_scores_gemma":[0.99957204,0.00001927192,0.00007036475,0.00020950666,0.0000932962,0.000035499314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002127355,0.00016259427,0.00022596045,0.00022077978,0.000118235046,0.000034615703,0.00011203888,0.000104109684,0.0003577859],"category_scores_gemma":[0.000033763394,0.00015539437,0.000052243056,0.00012213393,0.00007886547,0.00012216123,0.00011056713,0.00016160608,0.00070224016],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034805818,0.00012777228,0.009940735,0.0000066685366,0.000033021486,0.00000697173,0.00048696154,0.000009403097,0.97603536,0.00060143776,0.011621492,0.0007821058],"study_design_scores_gemma":[0.004580553,0.0004378493,0.4473773,0.00009065991,0.000028365988,0.00016438382,0.0026175082,0.000018419176,0.14092216,0.00011542543,0.40311208,0.00053528056],"about_ca_topic_score_codex":0.00020778891,"about_ca_topic_score_gemma":0.00008471873,"teacher_disagreement_score":0.8351132,"about_ca_system_score_codex":0.000069979345,"about_ca_system_score_gemma":0.000031204185,"threshold_uncertainty_score":0.902611},"labels":[],"label_agreement":null},{"id":"W1960346620","doi":"10.1080/19420862.2015.1057364","title":"Structure-guided residence time optimization of a dabigatran reversal agent","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Dabigatran; Idarucizumab; In vivo; Chemistry; Pharmacology; Medicine; Warfarin; Internal medicine; Biology; Atrial fibrillation","score_opus":0.046522613258959435,"score_gpt":0.3073776250928099,"score_spread":0.26085501183385046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960346620","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049911052,0.00005941151,0.94759965,0.00079829124,0.00029915353,0.00012552043,0.0000067334645,0.00007112487,0.0011290754],"genre_scores_gemma":[0.4075178,0.0000016943752,0.59201086,0.00014391834,0.000049336668,0.0000022952713,0.000009482401,0.0000073910696,0.00025724628],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99876785,0.0001782931,0.0002379055,0.00024806792,0.00042499515,0.00014289051],"domain_scores_gemma":[0.99909306,0.000110020796,0.00011211473,0.0003759362,0.00020823815,0.00010063838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048160396,0.00008923864,0.00013188944,0.00008736366,0.00002889736,0.000051969084,0.0005376984,0.000036981994,0.000038327373],"category_scores_gemma":[0.00028775082,0.0000859121,0.000039339666,0.00037035198,0.000038178994,0.00040183793,0.00019527016,0.000060888437,0.000023177165],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009739997,0.00001508442,0.00008706526,0.000009912623,0.0000073581327,0.00000781757,0.000534362,0.983814,0.0013936493,0.008988583,0.0030210274,0.0021113984],"study_design_scores_gemma":[0.00034230002,0.000055086028,0.0014225579,0.00002684582,0.000006353945,0.000026894757,0.00001142817,0.9713685,0.0061941957,0.020190729,0.00022491303,0.00013021928],"about_ca_topic_score_codex":0.00003266102,"about_ca_topic_score_gemma":0.000002093481,"teacher_disagreement_score":0.35760674,"about_ca_system_score_codex":0.00006707541,"about_ca_system_score_gemma":0.00020854876,"threshold_uncertainty_score":0.35033938},"labels":[],"label_agreement":null},{"id":"W1967888916","doi":"10.4161/mabs.36336","title":"Characterization of a plant-produced recombinant human secretory IgA with broad neutralizing activity against HIV","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Transgenic Plants and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Glycosylation; Recombinant DNA; Monoclonal antibody; Nicotiana benthamiana; Antibody; Glycan; Biology; Transgene; Microbiology; Virology; Glycoprotein; Chemistry; Molecular biology; Virus; Biochemistry; Immunology; Gene","score_opus":0.01082470946357555,"score_gpt":0.21829515645667152,"score_spread":0.20747044699309597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967888916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980523,0.0000067920573,0.0011925551,0.00013829135,0.000035785164,0.00013316808,0.00008201013,0.000013180833,0.0003459366],"genre_scores_gemma":[0.9985624,0.000029092947,0.00006277735,0.00006793558,0.00007009758,0.00001970239,0.00095857424,0.000012436036,0.00021699259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949515,0.000018858305,0.00010146107,0.00021214888,0.00005682566,0.00011555966],"domain_scores_gemma":[0.9996115,0.0000024289373,0.00008194127,0.000242098,0.000026753018,0.00003527859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069646616,0.00008660168,0.00010227797,0.000019420188,0.00006738127,0.000008360019,0.000092178736,0.000060138565,0.0000052438377],"category_scores_gemma":[0.000002820581,0.00007411179,0.000029559284,0.000040806488,0.000032311877,0.0000037771636,0.000016911647,0.00004796207,0.0000026105356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004112406,0.000050306353,0.0015520578,0.000020831554,0.00001551868,2.5263822e-7,0.000028345927,0.0000049760542,0.9968368,0.00016562242,0.00008649228,0.0011977085],"study_design_scores_gemma":[0.00041751136,0.000109088876,0.06452052,0.000025220636,0.000012367037,0.0000040060304,0.0000072348944,0.000049587434,0.9142967,0.000011076427,0.020420488,0.00012621937],"about_ca_topic_score_codex":0.000013666454,"about_ca_topic_score_gemma":0.00003473066,"teacher_disagreement_score":0.08254009,"about_ca_system_score_codex":0.0000043694236,"about_ca_system_score_gemma":0.000018037397,"threshold_uncertainty_score":0.30221912},"labels":[],"label_agreement":null},{"id":"W1968872582","doi":"10.4161/mabs.22221","title":"IBC’s 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society","year":2012,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Antibody; Medicine; Bispecific antibody; Intellectual property; Immunology; Political science; Law; Monoclonal antibody","score_opus":0.023411260382498446,"score_gpt":0.3220305306022519,"score_spread":0.29861927021975343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968872582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98631376,0.0070810984,0.000081920305,0.004011267,0.00017507214,0.00035656002,0.000037239395,0.000023582455,0.001919505],"genre_scores_gemma":[0.9957378,0.0026473016,0.00029824095,0.00045748308,0.00028097242,0.0000043073396,0.00002058589,0.000018346243,0.0005349469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985891,0.00009289244,0.0002755316,0.00018584875,0.0004303214,0.00042630915],"domain_scores_gemma":[0.99902546,0.00038213417,0.00009861734,0.00023646628,0.00013964332,0.00011767825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081504893,0.00019679974,0.00036662671,0.00003771594,0.000230148,0.000038226404,0.0001688761,0.00009535964,0.000030162175],"category_scores_gemma":[0.000077935896,0.00009686911,0.0001443927,0.00017896375,0.00065327494,0.00011019408,0.00025983521,0.0003511842,0.000003294783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036449576,0.00013921666,0.8011241,0.00060640735,0.00048677734,0.0000038793046,0.0064315917,0.0000056709737,0.1714875,0.01547174,0.00026083947,0.003617781],"study_design_scores_gemma":[0.0027545346,0.00020475489,0.93134385,0.0004517276,0.00029029074,0.00019525395,0.0035674726,0.005511539,0.009681677,0.00017903112,0.045500197,0.00031965674],"about_ca_topic_score_codex":0.00027790348,"about_ca_topic_score_gemma":0.0000044919475,"teacher_disagreement_score":0.16180582,"about_ca_system_score_codex":0.000010334807,"about_ca_system_score_gemma":0.000064594205,"threshold_uncertainty_score":0.39502075},"labels":[],"label_agreement":null},{"id":"W1969854934","doi":"10.4161/mabs.4.1.18529","title":"New developments in malaria diagnostics","year":2012,"lang":"en","type":"article","venue":"mAbs","topic":"Malaria Research and Control","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Plasmodium falciparum; Antigen; Monoclonal antibody; Antibody; Dihydrofolate reductase; Virology; Plasmodium vivax; Molecular biology; Immunogenicity; Chemistry; Biology; Malaria; Enzyme; Biochemistry; Immunology","score_opus":0.020319141837891914,"score_gpt":0.29238692808866185,"score_spread":0.27206778625076994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969854934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69359505,0.007837813,0.006244852,0.05765777,0.0016644165,0.0026678864,0.00001116686,0.00021327425,0.23010777],"genre_scores_gemma":[0.99016994,0.00006392733,0.0025455763,0.0005294394,0.00023119932,0.000016019809,0.0000086080245,0.000008024234,0.006427289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993106,0.00001724045,0.00010175324,0.00006996951,0.00017848912,0.00032194445],"domain_scores_gemma":[0.99953544,0.000053687356,0.000011484372,0.00011184714,0.000021651886,0.00026587778],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017258886,0.000054826778,0.000104546365,0.00006718466,0.00001434691,0.000008177751,0.000046696146,0.00004547457,0.0009920936],"category_scores_gemma":[0.00040904136,0.000045671455,0.000018270905,0.00010550799,0.0000068666263,0.00005077907,0.000033850283,0.00012784729,0.0005247003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019288789,0.00016093528,0.90319365,0.000034046472,0.000032202068,0.000082545106,0.00024571366,2.425957e-7,0.00080650824,0.01985873,0.025095908,0.0502966],"study_design_scores_gemma":[0.0016165166,0.000033313256,0.9305868,0.000029192077,0.000007804249,0.000010505443,0.000020063995,0.000011785095,0.00032600126,0.0001209936,0.067187496,0.000049517042],"about_ca_topic_score_codex":0.000104393555,"about_ca_topic_score_gemma":0.000024757375,"teacher_disagreement_score":0.29657486,"about_ca_system_score_codex":0.000047606456,"about_ca_system_score_gemma":0.00013324227,"threshold_uncertainty_score":0.99992114},"labels":[],"label_agreement":null},{"id":"W1995374080","doi":"10.4161/mabs.25632","title":"Improving biophysical properties of a bispecific antibody scaffold to aid developability","year":2013,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Zymeworks (Canada)","funders":"","keywords":"Scaffold; Critical quality attributes; Bispecific antibody; Computer science; Nanotechnology; Biochemical engineering; Computational biology; Process (computing); Quality by Design; Upstream (networking); Structural similarity; Downstream (manufacturing); Monoclonal antibody; Antibody; Materials science; Biology; Artificial intelligence; Engineering; Immunology","score_opus":0.03348512112501264,"score_gpt":0.29602221536688617,"score_spread":0.26253709424187355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995374080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427515,0.00013674714,0.000060401646,0.003512227,0.00006409946,0.00057686085,0.000006177529,0.00003377198,0.0013345553],"genre_scores_gemma":[0.9947726,0.000012156823,0.0015689771,0.0002188852,0.00014985434,0.000039718423,0.000008244918,0.000014595987,0.0032149318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987533,0.000030384133,0.000265639,0.00026007404,0.00037713844,0.0003134544],"domain_scores_gemma":[0.9991708,0.000030405461,0.00003584442,0.00026969664,0.00028567194,0.0002076081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013795406,0.00012862928,0.00029458644,0.00010578982,0.000061766754,0.000022689526,0.00013072186,0.000049452137,0.00045430835],"category_scores_gemma":[0.00012719182,0.0000846312,0.00009220522,0.0002728593,0.0001478764,0.00007636638,0.00016208291,0.00012595824,0.0006950777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002249271,0.00017755757,0.021519784,0.00038079248,0.000023347813,0.0000065621734,0.00016761826,4.3768824e-7,0.96339315,0.0002767205,0.00073387224,0.013095223],"study_design_scores_gemma":[0.0006534458,0.0006708112,0.36967534,0.0002798548,0.00002039122,0.000028200737,0.00022778191,0.0007006774,0.6175506,0.00012868766,0.009817141,0.00024707068],"about_ca_topic_score_codex":0.0014231576,"about_ca_topic_score_gemma":0.000010547127,"teacher_disagreement_score":0.34815556,"about_ca_system_score_codex":0.000037517148,"about_ca_system_score_gemma":0.0001081812,"threshold_uncertainty_score":0.89340496},"labels":[],"label_agreement":null},{"id":"W1997514113","doi":"10.4161/mabs.28421","title":"Antibody Engineering and Therapeutics","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Antibody; Computational biology; Immunotherapy; Antibody-drug conjugate; Bispecific antibody; Antibody Repertoire; Biology; Immunology; Monoclonal antibody; Immune system","score_opus":0.018885056357545654,"score_gpt":0.3134748275983281,"score_spread":0.29458977124078245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997514113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98863435,0.00050545705,0.00073430955,0.002535097,0.0000545842,0.00006682298,0.0000013839252,0.000034639612,0.0074333455],"genre_scores_gemma":[0.9960823,0.00017364441,0.0007351945,0.00059605873,0.00017052738,0.0000016168536,0.000012892059,0.000008802607,0.002218977],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960536,0.000007413376,0.00005935663,0.00008441488,0.00011343085,0.00013002862],"domain_scores_gemma":[0.9997739,0.00004437386,0.000006851294,0.00008172285,0.00002304828,0.00007009967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084248255,0.00005428326,0.00009282266,0.00003598564,0.000028470839,0.0000104039345,0.000026389464,0.000027425955,0.000058094913],"category_scores_gemma":[0.000018447672,0.000039714374,0.000021764215,0.000043994918,0.000025688829,0.0000149096395,0.000027859016,0.00009519983,0.000045206183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022916844,0.00010588901,0.18801884,0.00048508082,0.00015010085,0.000052251897,0.00036655797,0.000011708604,0.6882847,0.019526238,0.00045871074,0.10231077],"study_design_scores_gemma":[0.00060729595,0.00027180655,0.28088176,0.00006030936,0.000026321135,0.00011316689,0.000016679109,0.016739776,0.004656177,0.00022757439,0.69627917,0.00011994384],"about_ca_topic_score_codex":0.000016720438,"about_ca_topic_score_gemma":6.9992944e-7,"teacher_disagreement_score":0.69582045,"about_ca_system_score_codex":0.000004462949,"about_ca_system_score_gemma":0.0000068049508,"threshold_uncertainty_score":0.16195051},"labels":[],"label_agreement":null},{"id":"W2005205132","doi":"10.4161/mabs.29445","title":"Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Fragment crystallizable region; Antibody; In vivo; Chemistry; Fusion protein; Flow cytometry; Molecular biology; Bispecific antibody; Immunoglobulin G; Effector; Receptor; Biophysics; Cell biology; Cancer research; Biochemistry; Immunology; Monoclonal antibody; Biology; Recombinant DNA","score_opus":0.017909422338928928,"score_gpt":0.3110017993956021,"score_spread":0.2930923770566731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005205132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192935,0.0028568371,0.00058356114,0.0032382205,0.00008326874,0.0003354237,0.000023109296,0.000018257473,0.0009319558],"genre_scores_gemma":[0.9959626,0.0010373689,0.00074561534,0.00023191447,0.00012198508,0.000010901606,0.000017591088,0.000014410828,0.0018575729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889416,0.00010927388,0.00017681827,0.0002542952,0.00032782543,0.00023762562],"domain_scores_gemma":[0.9992162,0.0002680159,0.00009500675,0.00016564522,0.00016646335,0.00008865812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044121125,0.0001409162,0.00024701195,0.00008926687,0.00016709266,0.000033345048,0.00008227779,0.00004325462,0.000044558205],"category_scores_gemma":[0.00011669843,0.00009174893,0.00003658552,0.00024331613,0.0002011892,0.000080781734,0.00005152319,0.00017232502,0.000004343763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006117092,0.00006137403,0.0026328352,0.00055916375,0.000031225445,0.0000068240884,0.0001364887,0.0000011697102,0.9888555,0.0007655963,0.00018726499,0.006150858],"study_design_scores_gemma":[0.0025581594,0.0004061019,0.2001591,0.00044537752,0.0000956324,0.000020622228,0.00015554862,0.0076694977,0.7304711,0.00020052744,0.05751474,0.00030361285],"about_ca_topic_score_codex":0.000038571186,"about_ca_topic_score_gemma":0.0000347886,"teacher_disagreement_score":0.2583844,"about_ca_system_score_codex":0.000010356436,"about_ca_system_score_gemma":0.00004653342,"threshold_uncertainty_score":0.37414128},"labels":[],"label_agreement":null},{"id":"W2008925833","doi":"10.4161/mabs.3.1.14168","title":"A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor","year":2011,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bible College; University of Calgary","funders":"","keywords":"Epidermal growth factor receptor; Cetuximab; A431 cells; Cancer research; Epidermal growth factor; Growth factor receptor; Phosphorylation; Chemistry; Receptor; EGFR inhibitors; Cell growth; Growth factor receptor inhibitor; Growth factor; Molecular biology; Cell biology; Biology; Cell; Biochemistry; Monoclonal antibody; Antibody; Cell cycle; Immunology; Oncogene","score_opus":0.05535978460188025,"score_gpt":0.2740891357391847,"score_spread":0.21872935113730446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008925833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851025,0.0008720411,0.00007742558,0.00093099463,0.00038662492,0.0007841866,0.00020801282,0.00007988868,0.008150572],"genre_scores_gemma":[0.98886746,0.00053325633,0.0062976507,0.00027434094,0.00044213605,0.000045226025,0.00007260582,0.00006140049,0.003405894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973713,0.00013338584,0.00058165437,0.0006310745,0.0006629975,0.0006195754],"domain_scores_gemma":[0.9984171,0.00016750909,0.00013583769,0.0003358867,0.00031187828,0.0006318032],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024654475,0.0003653098,0.00065817824,0.00038585486,0.00013322606,0.000027047063,0.00023502484,0.0002152124,0.001272327],"category_scores_gemma":[0.00026395495,0.00028573358,0.00018562259,0.00051131577,0.00023594996,0.00015315662,0.00026413292,0.0003786864,0.00027382973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01037522,0.0033391307,0.4308289,0.004180987,0.0008648422,0.00007132874,0.017467992,5.981821e-7,0.37020838,0.007296415,0.11569484,0.03967137],"study_design_scores_gemma":[0.0037160155,0.003271527,0.5933806,0.0005781495,0.00007949458,0.000118269214,0.0011115862,0.000057044505,0.3224147,0.0003311635,0.07377846,0.0011630114],"about_ca_topic_score_codex":0.0010713623,"about_ca_topic_score_gemma":0.000012023767,"teacher_disagreement_score":0.16255169,"about_ca_system_score_codex":0.00008146469,"about_ca_system_score_gemma":0.00010150116,"threshold_uncertainty_score":0.99995947},"labels":[],"label_agreement":null},{"id":"W2013063563","doi":"10.4161/mabs.1.6.10221","title":"Americas Antibody Congress","year":2009,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute; Abbott (Canada)","funders":"","keywords":"Immunogenicity; Dialog box; Antibody; Library science; Medicine; Computer science; Immunology; World Wide Web","score_opus":0.032001147947808894,"score_gpt":0.3917552252010655,"score_spread":0.3597540772532566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013063563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9057622,0.0005759609,0.000054027692,0.015836127,0.00013425827,0.00015703728,0.000006624555,0.00006604018,0.077407725],"genre_scores_gemma":[0.9702775,0.00017414961,0.00043395834,0.0028042065,0.00023785015,0.0000018477581,0.000039983668,0.0000065836316,0.026023937],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992109,0.000022822094,0.00011419385,0.00014909492,0.000261718,0.00024129006],"domain_scores_gemma":[0.99955946,0.000038669925,0.000020415791,0.0001635146,0.00006882783,0.0001490879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009662854,0.00008391331,0.00017434215,0.000060016348,0.000058243426,0.000014946327,0.00007136217,0.00003582237,0.0007529165],"category_scores_gemma":[0.000049493017,0.000061024228,0.000071671246,0.00014131272,0.00007164117,0.00003121701,0.00002167132,0.00014749727,0.0005880281],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031698577,0.00106848,0.1377994,0.00019839544,0.00018685123,0.0027204216,0.00035894214,0.0000039064435,0.3843944,0.016968003,0.116793506,0.33633783],"study_design_scores_gemma":[0.00077993574,0.0008181473,0.52406704,0.00006336727,0.000021600732,0.00024151611,0.00004091648,0.00022013353,0.007171709,0.00055571535,0.4658717,0.00014821331],"about_ca_topic_score_codex":0.000051620038,"about_ca_topic_score_gemma":0.000001106655,"teacher_disagreement_score":0.38626766,"about_ca_system_score_codex":0.000013924848,"about_ca_system_score_gemma":0.00003229991,"threshold_uncertainty_score":0.82439077},"labels":[],"label_agreement":null},{"id":"W2021301420","doi":"10.4161/19420862.2014.985933","title":"Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Linker; Internalization; Single-chain variable fragment; Complementarity determining region; Chemistry; Antibody; Protein engineering; Peptide; Cytotoxic T cell; Computational biology; Ligand (biochemistry); Peptide library; Biophysics; Immunoglobulin light chain; Monoclonal antibody; Biochemistry; Biology; Computer science; Peptide sequence; In vitro; Immunology; Cell; Receptor; Gene","score_opus":0.02194264055113981,"score_gpt":0.30084955641920214,"score_spread":0.2789069158680623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021301420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556991,0.00022359683,0.040680744,0.0012866667,0.0000683881,0.0006322284,0.000016011125,0.00002866813,0.0013645879],"genre_scores_gemma":[0.9533782,0.000022495136,0.044972792,0.00046074428,0.00015194561,0.000039623315,0.000098432676,0.000022479353,0.00085326494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884063,0.00005966292,0.00029464407,0.00021637153,0.000282781,0.0003058996],"domain_scores_gemma":[0.99915284,0.00024048466,0.00008909906,0.00015433047,0.00024750404,0.00011573718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000311334,0.00012124508,0.00030014824,0.00007869624,0.000108625296,0.000017613032,0.00007028208,0.00006227272,0.00010842573],"category_scores_gemma":[0.00020472257,0.00009981592,0.00008095009,0.00017516987,0.00007523973,0.000042891308,0.00006017385,0.00007811188,0.000017292972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074810884,0.00025607075,0.0009074918,0.0004058265,0.000055587454,0.0000057763064,0.00027073504,0.0022109963,0.99124694,0.003094506,0.00047354892,0.00032439295],"study_design_scores_gemma":[0.0051274286,0.0035809418,0.00082052493,0.00047572897,0.00008187415,0.000059335416,0.0004960303,0.12347604,0.8122672,0.0036713334,0.049624283,0.000319315],"about_ca_topic_score_codex":0.00009788454,"about_ca_topic_score_gemma":0.0000014281376,"teacher_disagreement_score":0.1789798,"about_ca_system_score_codex":0.000031803647,"about_ca_system_score_gemma":0.00005141529,"threshold_uncertainty_score":0.40703753},"labels":[],"label_agreement":null},{"id":"W2026122112","doi":"10.4161/mabs.1.2.7945","title":"High level expression of functional human IgMs in human PER.C6® cells","year":2009,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Recombinant DNA; Cell culture; Antibody; Biology; Monoclonal antibody; Cytotoxicity; Random hexamer; Chinese hamster ovary cell; Immunoglobulin M; Molecular biology; Immunoglobulin G; Biochemistry; Gene; Immunology; In vitro; Genetics","score_opus":0.06835872217654829,"score_gpt":0.33752650002827655,"score_spread":0.2691677778517283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026122112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919704,0.00011923382,0.000033980283,0.0012677293,0.00006951287,0.00014643068,0.000018531475,0.000016486121,0.006357683],"genre_scores_gemma":[0.9807052,0.000015308207,0.0003146206,0.0002503965,0.00022811275,0.0000048398542,0.00008678148,0.000008451279,0.018386312],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99885076,0.000032633176,0.0002659729,0.00019570533,0.00042777686,0.00022717657],"domain_scores_gemma":[0.9995769,0.000030049623,0.00004602209,0.00017511773,0.00007463331,0.000097260265],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014842433,0.00011052638,0.00023968423,0.00015421206,0.00009107429,0.0000070967903,0.00008660667,0.00007700543,0.0019913225],"category_scores_gemma":[0.000010677757,0.000085332584,0.000082079336,0.00010740758,0.00006930466,0.000043183343,0.000041831983,0.0002314247,0.000064664935],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021279413,0.00031049352,0.0057219793,0.000060853476,0.0000069529083,0.000037049216,0.000104422994,0.000017147913,0.982307,0.0034352844,0.0064658215,0.0013201594],"study_design_scores_gemma":[0.0013582717,0.0005506102,0.642224,0.00016847762,0.000008583658,0.000011754269,0.000049885046,0.000017554303,0.34854034,0.0017915169,0.0051681437,0.00011084401],"about_ca_topic_score_codex":0.0003567972,"about_ca_topic_score_gemma":0.000029008936,"teacher_disagreement_score":0.636502,"about_ca_system_score_codex":0.000035776968,"about_ca_system_score_gemma":0.00003158714,"threshold_uncertainty_score":0.998921},"labels":[],"label_agreement":null},{"id":"W2026422641","doi":"10.4161/mabs.25488","title":"LC-MS characterization and purity assessment of a prototype bispecific antibody","year":2013,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Chemistry; Peptide; Antibody; Immunoglobulin light chain; Chromatography; Mass spectrometry; Bispecific antibody; Biochemistry; Monoclonal antibody; Biology","score_opus":0.023021944035913046,"score_gpt":0.3469722821506933,"score_spread":0.32395033811478025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026422641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274,0.00006453925,0.00021845056,0.002324948,0.000041325504,0.00090593006,0.000013355549,0.000015669402,0.0036758254],"genre_scores_gemma":[0.99572265,0.00022478688,0.00057194254,0.00009388813,0.00009250627,0.000060254424,0.00013847824,0.000008454148,0.003087034],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99927574,0.00002729966,0.00016616056,0.00014288275,0.00024315354,0.00014473428],"domain_scores_gemma":[0.9995721,0.000020844478,0.00004621396,0.0001300429,0.00013895473,0.00009184415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000105791696,0.00007599138,0.00017752535,0.000071703376,0.000041653195,0.00001991459,0.000042738997,0.000043638538,0.0010799879],"category_scores_gemma":[0.000016184153,0.000055167075,0.00003217653,0.00010910091,0.00007786388,0.000076094795,0.000049865877,0.00011267467,0.00004934821],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008687883,0.00015440746,0.348619,0.00034320485,0.000028983512,0.000007959458,0.000064071246,5.1540674e-8,0.63501465,0.0014826852,0.00017682559,0.014021257],"study_design_scores_gemma":[0.00034763626,0.00036827152,0.97766846,0.00006622076,0.000008585851,0.000017762435,0.000014185224,0.00079677324,0.004061888,0.00009877863,0.016493987,0.000057426005],"about_ca_topic_score_codex":0.0002033411,"about_ca_topic_score_gemma":0.0000023192292,"teacher_disagreement_score":0.6309528,"about_ca_system_score_codex":0.000013107566,"about_ca_system_score_gemma":0.00004435429,"threshold_uncertainty_score":0.99983317},"labels":[],"label_agreement":null},{"id":"W2031040204","doi":"10.4161/mabs.27029","title":"IgE immunotherapy","year":2013,"lang":"de","type":"review","venue":"mAbs","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Academy of Medical Sciences; National Institute for Health and Care Research; Cancer Research UK","keywords":"Effector; Immunoglobulin E; Immune system; Antibody; Immunotherapy; Immunology; Cancer immunotherapy; Blockade; Immune checkpoint; Biology; Receptor; Cancer research","score_opus":0.021998507567874078,"score_gpt":0.2621774546803293,"score_spread":0.24017894711245524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031040204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003760047,0.97876704,0.000036574187,0.00016132666,0.004696003,0.001012923,0.00016982584,0.00007112468,0.015047565],"genre_scores_gemma":[0.000023586055,0.7882848,0.00005929914,0.00023614443,0.0003379634,0.00012853793,0.0012000515,0.00008412318,0.20964551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971258,0.00042876112,0.0009330498,0.0006849362,0.00005602333,0.0007714384],"domain_scores_gemma":[0.99813324,0.00015812668,0.00052870484,0.0010187532,0.00010832885,0.000052820014],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00027251546,0.00076051184,0.0020147748,0.00020390407,0.0003110881,0.00006739195,0.0007151012,0.0013975349,0.14172505],"category_scores_gemma":[0.000022265036,0.00060419174,0.0007557496,0.00018821203,0.00035524784,0.000051915646,0.00017824309,0.0010560907,0.17632535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026038815,0.00018864268,0.0000044393455,0.0037157882,0.0010614838,0.000018379462,0.00013158922,3.9747107e-8,0.0015905283,0.0020552517,0.09419088,0.89701694],"study_design_scores_gemma":[0.0007171199,0.00019370747,0.000012391382,0.001700522,0.00035689594,0.00008026563,0.000020609905,2.7084508e-7,0.00005383815,0.000055591445,0.99617726,0.00063152553],"about_ca_topic_score_codex":0.00026296085,"about_ca_topic_score_gemma":0.0000134558095,"teacher_disagreement_score":0.90198636,"about_ca_system_score_codex":0.000106095256,"about_ca_system_score_gemma":0.000184165,"threshold_uncertainty_score":0.99989885},"labels":[],"label_agreement":null},{"id":"W2031687582","doi":"10.4161/mabs.28786","title":"Insights into HER2 signaling from step-by-step optimization of anti-HER2 antibodies","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Pertuzumab; Trastuzumab; Antibody; Monoclonal antibody; Epitope; Phage display; Signal transduction; Cetuximab; Blocking antibody; Cancer research; Receptor tyrosine kinase; Paratope; Computational biology; Chemistry; Cancer; Breast cancer; Biology; Biochemistry; Immunology; Genetics","score_opus":0.016580476613198128,"score_gpt":0.28340841940727846,"score_spread":0.26682794279408034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031687582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95886827,0.0016810285,0.03206631,0.000895837,0.00016431468,0.00024168797,0.00002222441,0.000054443193,0.0060059056],"genre_scores_gemma":[0.98102,0.00033616254,0.016144386,0.0003220865,0.00024347707,0.000005857923,0.00026159358,0.000027879223,0.0016385942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998529,0.000099530356,0.00035885163,0.0002930586,0.0004838319,0.00023569289],"domain_scores_gemma":[0.9990836,0.00018873891,0.00010899576,0.00026384773,0.00021124864,0.00014359466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013999424,0.0001779044,0.0004312232,0.0001180171,0.00011325589,0.000023848168,0.00014666631,0.00011617747,0.00047920583],"category_scores_gemma":[0.00010636389,0.00013767288,0.00010643729,0.0001811329,0.00014508078,0.00009235498,0.00009686896,0.00018697175,0.00007640653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012135019,0.0008933247,0.10667772,0.0012424374,0.00066460954,0.000074586125,0.0015097924,0.003961779,0.8178875,0.003622074,0.043561116,0.01869159],"study_design_scores_gemma":[0.0055181123,0.0017909369,0.078713685,0.0015389947,0.00031462882,0.000019994217,0.0008305624,0.22125497,0.364999,0.0011646381,0.3227647,0.0010897961],"about_ca_topic_score_codex":0.0022559338,"about_ca_topic_score_gemma":0.00003911965,"teacher_disagreement_score":0.4528885,"about_ca_system_score_codex":0.000026938378,"about_ca_system_score_gemma":0.0000420737,"threshold_uncertainty_score":0.5614137},"labels":[],"label_agreement":null},{"id":"W2034834217","doi":"10.4161/mabs.3.2.14858","title":"Molecular characterization of the cervical and systemic B-cell repertoire","year":2011,"lang":"en","type":"article","venue":"mAbs","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Burnaby Hospital; Simon Fraser University; University of Manitoba; Manitoba Beekeepers' Association","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Public Health Agency; Bill and Melinda Gates Foundation","keywords":"Germinal center; B cell; Biology; Antibody; Immunoglobulin class switching; Memory B cell; Immune system; Immunology; Repertoire; Gene; Naive B cell; Genetics; T cell; Antigen-presenting cell","score_opus":0.010632715282770244,"score_gpt":0.19968692909324878,"score_spread":0.18905421381047854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034834217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978443,0.0005521088,0.000025168945,0.00006831797,0.000057168567,0.000112664406,0.000017682532,0.000007428713,0.0013152091],"genre_scores_gemma":[0.999038,0.000031961492,0.000004923407,0.00002485574,0.000001967153,0.000008585922,0.000026574571,0.0000032013972,0.0008599554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968773,0.00007144244,0.00007030663,0.00007470808,0.000014057018,0.00008176375],"domain_scores_gemma":[0.99980396,0.0000066057214,0.000027486554,0.00013466123,0.000019343795,0.000007914112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036801182,0.000038099213,0.0000623687,0.000013797432,0.000040179948,0.0000015711987,0.000059295486,0.000051550942,0.00014894281],"category_scores_gemma":[0.0000070405267,0.000022634673,0.000021625556,0.000030366125,0.00006350437,0.000012503536,0.000043676886,0.00004761502,0.000112132686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002704127,0.0000536597,0.011739864,0.00002460665,0.000022965061,0.000003612284,0.00034545417,1.0175654e-8,0.98634255,0.00024063003,0.000020566138,0.001179041],"study_design_scores_gemma":[0.0006066845,0.000089492874,0.1310127,0.000027432601,0.000016505455,0.00005104736,0.00005854089,0.0000010501147,0.8668544,0.000029903505,0.0012131167,0.000039118197],"about_ca_topic_score_codex":0.000036738737,"about_ca_topic_score_gemma":0.000001608254,"teacher_disagreement_score":0.11948814,"about_ca_system_score_codex":0.0000061837627,"about_ca_system_score_gemma":0.000012035598,"threshold_uncertainty_score":0.16308194},"labels":[],"label_agreement":null},{"id":"W2035276582","doi":"10.4161/mabs.27828","title":"Comparative reactivity of human IgE to cynomolgus monkey and human effector cells and effects on IgE effector cell potency","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Academy of Medical Sciences; National Institute for Health and Care Research; Cancer Research UK","keywords":"Effector; Immunoglobulin E; Immune system; Biology; Immunology; Antibody; Potency; Receptor; In vitro; Cell biology; Biochemistry","score_opus":0.020414206490558667,"score_gpt":0.3209488151709028,"score_spread":0.3005346086803441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035276582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991488,0.00014749743,0.000015970189,0.00022360953,0.00007758345,0.0009540496,0.000035753877,0.000028586544,0.0070289467],"genre_scores_gemma":[0.99732214,0.0000120998875,0.00011470596,0.00020996679,0.00018964481,0.000034387333,0.000027026459,0.000022229802,0.0020677936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839383,0.00026452998,0.00021367786,0.0004239304,0.0003620222,0.00034200924],"domain_scores_gemma":[0.9984762,0.000731982,0.00007757309,0.00029428158,0.000071146584,0.00034883383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003483336,0.00026042614,0.00067281263,0.00016539765,0.00025618108,0.000018511342,0.000094052266,0.00009780436,0.000043723416],"category_scores_gemma":[0.000045189914,0.00019844674,0.00008101492,0.00011881055,0.00014323785,0.00004279389,0.00017107853,0.00029818865,0.00008742651],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000523402,0.00027689128,0.014055364,0.0012469132,0.000045064335,0.000036152764,0.000590406,6.1444086e-7,0.9787143,0.00030623836,0.001167845,0.0030368029],"study_design_scores_gemma":[0.0014971938,0.005636908,0.3396095,0.00027755383,0.000048044767,0.000007755082,0.000014706439,0.000044156815,0.6490244,0.00008365054,0.0035715338,0.00018456834],"about_ca_topic_score_codex":0.0010672917,"about_ca_topic_score_gemma":0.00007040391,"teacher_disagreement_score":0.3296899,"about_ca_system_score_codex":0.000035460896,"about_ca_system_score_gemma":0.000014000015,"threshold_uncertainty_score":0.8092423},"labels":[],"label_agreement":null},{"id":"W2042396314","doi":"10.4161/mabs.1.1.7472","title":"Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma","year":2009,"lang":"en","type":"article","venue":"mAbs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; D. Warren Brown Family Foundation; Leukemia and Lymphoma Society; William K. Warren Foundation","keywords":"Bortezomib; Mantle cell lymphoma; Rituximab; Proteasome inhibitor; Cancer research; Medicine; Apoptosis; Protein kinase B; Proteasome; Lymphoma; Pharmacology; Internal medicine; Chemistry; Multiple myeloma; Biochemistry","score_opus":0.017791913357777203,"score_gpt":0.2454242294326189,"score_spread":0.2276323160748417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042396314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613625,0.0005094923,0.0000075873586,0.0011047539,0.000053819076,0.0009313603,0.00001586323,0.000041483472,0.0011993987],"genre_scores_gemma":[0.99870694,0.00026491747,0.0005754225,0.00016536006,0.00002520041,0.00008810054,0.000042349613,0.000013445549,0.00011827119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991092,0.000030599524,0.000145214,0.00033332192,0.00014654515,0.00023508513],"domain_scores_gemma":[0.9995329,0.00005458279,0.000036027686,0.0001783944,0.00002412791,0.00017396327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008392207,0.0001930807,0.00033227977,0.00011716433,0.00006238285,0.000033831522,0.000025623805,0.00006840619,0.000006250898],"category_scores_gemma":[0.000019782687,0.00015233009,0.00003936142,0.00010658763,0.000011272025,0.00005532322,0.000022319922,0.000021695523,0.000017699253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063891127,0.018730111,0.54340595,0.00012138107,0.000081985454,0.00035625114,0.0019315807,0.0000021092453,0.012730025,0.001190389,0.00023735322,0.42057392],"study_design_scores_gemma":[0.031222919,0.0027627253,0.9033009,0.00009798117,0.00008696637,0.000020572123,0.00010178062,0.00033933684,0.060831815,0.00015170616,0.0009187418,0.00016459906],"about_ca_topic_score_codex":0.00027170085,"about_ca_topic_score_gemma":0.000080629296,"teacher_disagreement_score":0.42040932,"about_ca_system_score_codex":0.00030616802,"about_ca_system_score_gemma":0.00003541179,"threshold_uncertainty_score":0.62118405},"labels":[],"label_agreement":null},{"id":"W2052533721","doi":"10.4161/mabs.1.4.9123","title":"Keystone Symposium on Antibodies as Drugs","year":2009,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Library science; Food and drug administration; Medicine; Management; Gerontology; Political science; Pharmacology","score_opus":0.01636230131064549,"score_gpt":0.32648484154529905,"score_spread":0.3101225402346536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052533721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7118116,0.00031103287,0.0000024310714,0.036353543,0.000098751254,0.00015526998,0.0000052207633,0.00006370572,0.25119847],"genre_scores_gemma":[0.91438997,0.00037375803,0.00012873168,0.005340852,0.0003487408,0.0000036526244,0.000027695394,0.000010848393,0.07937577],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880064,0.000024915398,0.00015586261,0.0002319124,0.0004613276,0.0003253229],"domain_scores_gemma":[0.9994263,0.000053908047,0.000025638574,0.00023858607,0.00007561048,0.00017996095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012039623,0.00014030542,0.00022994014,0.00011526251,0.0001121109,0.000021523792,0.000096320124,0.00006424435,0.00059632765],"category_scores_gemma":[0.000036979152,0.000101880796,0.00010803901,0.00013076155,0.00007284598,0.00003767738,0.000029912228,0.0002286526,0.0021334437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008664825,0.002730093,0.024166815,0.00055032835,0.00039549673,0.0026592307,0.0037262554,0.000024852383,0.42662516,0.13208762,0.22642829,0.17194101],"study_design_scores_gemma":[0.0029402405,0.005720861,0.21922968,0.00053216494,0.00008466624,0.00042675098,0.0003314578,0.00021930491,0.1023087,0.005682388,0.66192454,0.00059921993],"about_ca_topic_score_codex":0.00009680592,"about_ca_topic_score_gemma":0.0000015678087,"teacher_disagreement_score":0.43549627,"about_ca_system_score_codex":0.00003440538,"about_ca_system_score_gemma":0.00004831015,"threshold_uncertainty_score":0.9986435},"labels":[],"label_agreement":null},{"id":"W2053214209","doi":"10.4161/mabs.2.2.11304","title":"Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2","year":2010,"lang":"en","type":"article","venue":"mAbs","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sunitinib; Cancer research; Vascular endothelial growth factor; Sorafenib; Kinase insert domain receptor; Kinase; Medicine; Vascular endothelial growth factor A; Pharmacology; Chemistry; Pathology; Renal cell carcinoma; VEGF receptors; Biochemistry; Hepatocellular carcinoma","score_opus":0.004967088243905219,"score_gpt":0.24310843828536727,"score_spread":0.23814135004146206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053214209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998564,0.00029978994,0.000037726757,0.000014943626,0.0005159869,0.00016910837,0.000095147974,0.000009061888,0.00029420032],"genre_scores_gemma":[0.9990223,0.00006901516,0.00015283308,0.0000454762,0.00051425735,0.00001712071,0.000049643124,0.00002866172,0.00010067846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910885,0.00007238621,0.0002119786,0.00027900763,0.00015516026,0.00017261399],"domain_scores_gemma":[0.99931383,0.000022939303,0.00012617464,0.00036000062,0.0001016403,0.00007544298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001922257,0.00015477906,0.00025363255,0.000038361864,0.00003563633,0.0000073188257,0.00018703045,0.00009459158,0.00029102332],"category_scores_gemma":[0.00016675612,0.00012718524,0.00021834092,0.00006529375,0.00009255642,0.000004588617,0.00006589332,0.00008419656,0.000014186605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097823446,0.000056487122,0.0245176,0.000058823112,0.000055511835,0.000001428374,0.000018576331,8.440789e-7,0.9732765,0.00005984972,0.00039302418,0.0014635528],"study_design_scores_gemma":[0.0006664116,0.00081394624,0.0056469925,0.00001286545,0.000024269713,0.0000070641922,0.000011806758,0.0000030967426,0.97474104,0.000010837521,0.017921122,0.00014053576],"about_ca_topic_score_codex":0.00013918613,"about_ca_topic_score_gemma":0.00002447153,"teacher_disagreement_score":0.018870607,"about_ca_system_score_codex":0.0000052044775,"about_ca_system_score_gemma":0.00005624423,"threshold_uncertainty_score":0.5186463},"labels":[],"label_agreement":null},{"id":"W2061828573","doi":"10.4161/mabs.2.1.10788","title":"Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology","year":2010,"lang":"en","type":"article","venue":"mAbs","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Toronto; University of Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Thailand Science Research and Innovation; Public Health Agency; National Cancer Institute; National Institutes of Health; Public Health Agency of Canada; University of Manitoba; University of Montana","keywords":"Epitope; Monoclonal antibody; Virology; Glycoprotein; Antigen; Antibody; Biology; Coronavirus; Epitope mapping; Fusion protein; Recombinant DNA; Chemistry; Molecular biology; Coronavirus disease 2019 (COVID-19); Immunology; Biochemistry; Medicine; Gene","score_opus":0.02628942709699998,"score_gpt":0.32596930581779304,"score_spread":0.29967987872079305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061828573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961507,0.00013136835,0.000016526452,0.0021890218,0.00020921895,0.0006277351,0.000013641857,0.00003936369,0.00062247086],"genre_scores_gemma":[0.9953488,0.0000022613583,0.00038666447,0.0040409695,0.00009699122,0.000017069688,9.558463e-7,0.000025356632,0.000080910075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859756,0.00004551973,0.00034946995,0.00027805998,0.0004325159,0.0002968913],"domain_scores_gemma":[0.99876314,0.000038852773,0.00014051284,0.00085263513,0.0001891142,0.000015731363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022113493,0.00015091445,0.0003451614,0.00022606933,0.00006613349,0.000011219827,0.00044415402,0.00033849225,0.000051053514],"category_scores_gemma":[0.0002931328,0.00008711264,0.000111042566,0.0004808923,0.0003163128,0.00004915773,0.00027650682,0.0006695494,0.0000082916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027988822,0.0000586501,0.036318783,0.00015786053,0.000045872923,0.00003276677,0.00015141658,1.6660488e-7,0.9559519,0.00074418506,0.00016351532,0.006094982],"study_design_scores_gemma":[0.0010763812,0.00015924673,0.011429768,0.00011589185,0.000021396208,0.00013197208,0.00012568507,0.000040547842,0.9589662,0.0012588123,0.026584173,0.00008990978],"about_ca_topic_score_codex":0.00032601893,"about_ca_topic_score_gemma":0.0006688369,"teacher_disagreement_score":0.026420657,"about_ca_system_score_codex":0.000026267167,"about_ca_system_score_gemma":0.00022238647,"threshold_uncertainty_score":0.355235},"labels":[],"label_agreement":null},{"id":"W2066353338","doi":"10.4161/mabs.26844","title":"Antibody light chain variable domains and their biophysically improved versions for human immunotherapy","year":2013,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Ottawa; Health Canada; Agricultural Institute of Canada; National Research Council Canada","funders":"","keywords":"Panning (audio); Phage display; Immunoglobulin light chain; Computational biology; Protein engineering; Antibody; Chemistry; Antigen; Peptide library; Disulfide bond; Immunotherapy; Biophysics; Molecular biology; Biochemistry; Combinatorial chemistry; Peptide sequence; Biology; Peptide; Immune system; Genetics; Gene","score_opus":0.011903443831836927,"score_gpt":0.2945818068941203,"score_spread":0.28267836306228333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066353338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845668,0.00038270216,0.0012953004,0.007926659,0.000081647486,0.0009872371,0.000046089965,0.00005078761,0.004662795],"genre_scores_gemma":[0.98184794,0.00016270771,0.002146632,0.0010269198,0.00036201303,0.000118631215,0.00019187081,0.000034053774,0.014109201],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991543,0.000021199232,0.0001559149,0.00022784309,0.000109641354,0.00033104265],"domain_scores_gemma":[0.9993754,0.00010254592,0.00003404545,0.00021979208,0.00012072744,0.00014750098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116621115,0.00014781218,0.00025211484,0.00007026413,0.00027235693,0.000042673684,0.00010003292,0.00007250605,0.0004114896],"category_scores_gemma":[0.000015839185,0.0000956975,0.00009502468,0.000107662316,0.00009151545,0.000066815475,0.00006432769,0.0001375874,0.000055518427],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016123912,0.00013930665,0.0004867753,0.00007608011,0.00009393811,0.0000018870965,0.000178634,7.5155555e-8,0.9885296,0.0061275046,0.0012153286,0.0029896286],"study_design_scores_gemma":[0.014406293,0.006266039,0.10274837,0.0004143408,0.00010692634,0.00010133665,0.0011089509,0.006949359,0.17172173,0.04170747,0.653304,0.0011652054],"about_ca_topic_score_codex":0.0005035934,"about_ca_topic_score_gemma":0.0000050446433,"teacher_disagreement_score":0.81680787,"about_ca_system_score_codex":0.0000200208,"about_ca_system_score_gemma":0.000039049406,"threshold_uncertainty_score":0.45055225},"labels":[],"label_agreement":null},{"id":"W2070645153","doi":"10.4161/mabs.1.5.9631","title":"Dimers and multimers of monoclonal IgG1 exhibit higher in vitro binding affinities to Fcγ receptors","year":2009,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Chemistry; Monoclonal antibody; Receptor; Fc receptor; Dissociation constant; In vitro; Biochemistry; Affinities; Surface plasmon resonance; Antigen; Cell surface receptor; Antibody; Ligand binding assay; Binding site; Plasma protein binding; Biophysics; Biology; Immunology","score_opus":0.029378260632597575,"score_gpt":0.31109444773482803,"score_spread":0.28171618710223045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070645153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98777795,0.00041775178,0.000002654965,0.0051533035,0.00011756198,0.0002273353,0.000017950608,0.000018752364,0.006266741],"genre_scores_gemma":[0.98989946,0.00011959654,0.0018131684,0.0006066987,0.00008184512,0.0000073224587,0.00002684601,0.000012158889,0.0074329213],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988477,0.00003395825,0.0002515834,0.00022907584,0.00031430268,0.00032334638],"domain_scores_gemma":[0.99949855,0.00010033145,0.00003789199,0.000120040306,0.00004913447,0.00019407253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017558192,0.00014108935,0.00030780214,0.00030557087,0.000044954184,0.000011460601,0.00007485269,0.00007105106,0.00041832434],"category_scores_gemma":[0.000047485417,0.00011726358,0.000064476895,0.0002614773,0.00009264793,0.000056261342,0.00005174314,0.0001934011,0.000052238796],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006528441,0.00044547956,0.067573264,0.0002405966,0.0001292459,0.00020244457,0.0026993526,0.000021787688,0.7891363,0.0012196128,0.0075163813,0.124287106],"study_design_scores_gemma":[0.004800809,0.0021848565,0.52155864,0.00065558124,0.00007342412,0.000063518586,0.0015282668,0.00047758807,0.38754588,0.00051012164,0.079843596,0.0007577266],"about_ca_topic_score_codex":0.0004312943,"about_ca_topic_score_gemma":0.000012479697,"teacher_disagreement_score":0.45398536,"about_ca_system_score_codex":0.000043843498,"about_ca_system_score_gemma":0.00003711864,"threshold_uncertainty_score":0.47818702},"labels":[],"label_agreement":null},{"id":"W2077812250","doi":"10.4161/mabs.23977","title":"Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule","year":2013,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Immunoglobulin domain; Antibody; Function (biology); Monoclonal antibody; Molecule; Chemistry; Computational biology; Flexibility (engineering); Fragment crystallizable region; Computer science; Biology; Cell biology; Immunology; Mathematics","score_opus":0.00876703802903499,"score_gpt":0.24444286135850027,"score_spread":0.23567582332946527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077812250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870253,0.00043975335,0.00008030548,0.0031198836,0.00019853137,0.0003952318,0.000034440232,0.000015818041,0.008690706],"genre_scores_gemma":[0.9820742,0.000017805723,0.0009045777,0.0007193532,0.00018256844,0.000013259337,0.000028310518,0.000012524975,0.016047377],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99895453,0.00006787293,0.00021498794,0.00015321067,0.000377844,0.00023156773],"domain_scores_gemma":[0.9993415,0.00004737305,0.00006322456,0.00031487204,0.00015948269,0.000073570125],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013230156,0.000105369305,0.00019148353,0.000038045357,0.00009511383,0.000015570866,0.00011443932,0.000086356566,0.0040804725],"category_scores_gemma":[0.00006208983,0.00006048903,0.00008675668,0.00022053155,0.000096045755,0.00004752069,0.00011452237,0.00023422163,0.00013625604],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002691545,0.00007788278,0.014572674,0.00019210059,0.00012173639,0.000007327694,0.00011686785,0.000012023494,0.94380677,0.008295986,0.030534431,0.0019930282],"study_design_scores_gemma":[0.0023791767,0.0007632378,0.80259633,0.00031745655,0.00011972125,0.0002005357,0.00039877254,0.00021561954,0.06819494,0.041184515,0.08331191,0.00031779197],"about_ca_topic_score_codex":0.00068794214,"about_ca_topic_score_gemma":0.000006613645,"teacher_disagreement_score":0.87561184,"about_ca_system_score_codex":0.000027377939,"about_ca_system_score_gemma":0.000066457105,"threshold_uncertainty_score":0.9968299},"labels":[],"label_agreement":null},{"id":"W2092059130","doi":"10.4161/mabs.36242","title":"Russell body phenotype is preferentially induced by IgG mAb clones with high intrinsic condensation propensity: Relations between the biosynthetic events in the ER and solution behaviors in vitro","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research Council Canada","keywords":"Golgi apparatus; Secretion; Endoplasmic reticulum; Antibody; Secretory pathway; Monoclonal antibody; Cell biology; Chemistry; Extracellular; Phenotype; Epitope; Biology; Biophysics; Biochemistry; Genetics; Gene","score_opus":0.028975479679776164,"score_gpt":0.27466640648728613,"score_spread":0.24569092680750998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092059130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989354,0.00004710816,0.00002735345,0.009548212,0.0000303017,0.0007276543,0.000016289314,0.000011241297,0.00023783268],"genre_scores_gemma":[0.99909776,0.0000192943,0.0000444471,0.00025199074,0.0000640247,0.000035923436,0.00011250656,0.000012702084,0.00036134533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987208,0.00025144956,0.00022100944,0.0002186026,0.00036919484,0.00021894426],"domain_scores_gemma":[0.999462,0.00014852962,0.00006688721,0.00021009232,0.000065277716,0.000047179088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048460404,0.00012652208,0.00019742857,0.000105911895,0.00013883287,0.00002267651,0.00010865046,0.00008725188,0.000056641817],"category_scores_gemma":[0.0000453135,0.00006626644,0.00002423247,0.0002293358,0.00009317874,0.00007209901,0.000056931312,0.0003606701,0.000032636184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002276565,0.0006001226,0.7956067,0.00014874621,0.000117086085,0.000008391412,0.003302354,0.0000025056693,0.16138981,0.0020755867,0.0005644183,0.03390774],"study_design_scores_gemma":[0.0010925807,0.00028286377,0.9854349,0.00007622042,0.00008319047,0.0000059210774,0.000077820165,0.000092907474,0.011365061,0.0007161449,0.0006697078,0.00010268558],"about_ca_topic_score_codex":0.0018961069,"about_ca_topic_score_gemma":0.00040067986,"teacher_disagreement_score":0.18982823,"about_ca_system_score_codex":0.00004174338,"about_ca_system_score_gemma":0.000048323356,"threshold_uncertainty_score":0.2866359},"labels":[],"label_agreement":null},{"id":"W2131592022","doi":"10.4161/mabs.28614","title":"A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Research Council Canada","keywords":"Monoclonal antibody; Antibody; Canakinumab; Potency; In vivo; Immunology; Cytokine; Medicine; Immune system; Rheumatoid arthritis; Arthritis; Neutralization; Neutralizing antibody; Pharmacology; In vitro; Disease; Biology; Internal medicine; Anakinra; Biochemistry","score_opus":0.01283484669469008,"score_gpt":0.2739818541241875,"score_spread":0.2611470074294974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131592022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552846,0.00012995575,0.0006686783,0.00010864759,0.0001290014,0.00010160732,0.0000027188034,0.000014846726,0.0033160928],"genre_scores_gemma":[0.9989119,0.000018148656,0.00016831546,0.00029013035,0.00013815315,0.0000062817403,0.00007782359,0.000024361567,0.00036485566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990738,0.00003194096,0.00022083557,0.00029169614,0.00007834044,0.000303386],"domain_scores_gemma":[0.9996079,0.000008724533,0.00004917415,0.00027186508,0.000026906977,0.000035409284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017367108,0.00015154041,0.00015584979,0.00006943251,0.00008467136,0.00003587292,0.00020163886,0.000108558736,0.000037798447],"category_scores_gemma":[0.000038292266,0.00015617747,0.000093833885,0.000074755444,0.000043436226,0.0000064006617,0.000102833015,0.00010601374,0.000012544198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002139892,0.000076526485,0.009448671,0.0000122326355,0.000017795752,0.0000022514246,0.00009084686,0.00010139343,0.9891517,0.00038578085,0.00017613226,0.0005152255],"study_design_scores_gemma":[0.0024696698,0.0002448446,0.07167305,0.00006892191,0.000013614705,0.000016126316,0.00015247127,0.00023146754,0.8854362,0.000053920754,0.039203163,0.00043659162],"about_ca_topic_score_codex":0.000086308755,"about_ca_topic_score_gemma":0.00007475424,"teacher_disagreement_score":0.10371559,"about_ca_system_score_codex":0.000011084577,"about_ca_system_score_gemma":0.000016962153,"threshold_uncertainty_score":0.63687325},"labels":[],"label_agreement":null},{"id":"W2200423187","doi":"10.1080/19420862.2015.1119352","title":"CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Medical Research Council; National Health and Medical Research Council; CSL Limited; State Government of Victoria; Australian Synchrotron; Australian Cancer Research Foundation","keywords":"Immunology; Cytokine; Eosinophil; Monoclonal antibody; Receptor; Epitope; Biology; Pharmacology; Antibody; Medicine; Asthma; Biochemistry","score_opus":0.028704842687410175,"score_gpt":0.29796769251035937,"score_spread":0.2692628498229492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200423187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97997373,0.013064439,0.00009706647,0.004483642,0.00020547345,0.0011902325,0.00088666665,0.00001928455,0.000079441226],"genre_scores_gemma":[0.99840415,0.0003749,0.000010491672,0.0005297817,0.00010077147,0.0000697663,0.00007193425,0.000019451503,0.00041876663],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991089,0.00008065246,0.00022970782,0.00015118968,0.00026718603,0.00016234191],"domain_scores_gemma":[0.9989271,0.000343506,0.00015007958,0.0003607294,0.00010207405,0.000116490926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001252281,0.00015516562,0.0002730593,0.000025888967,0.000120403616,0.000009899282,0.00014353295,0.000049773407,0.000014976509],"category_scores_gemma":[0.000072933275,0.000059347713,0.00015843299,0.00012426841,0.0003668531,0.000025083262,0.000031907013,0.000048736583,0.0000013143818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007661084,0.0093602305,0.55167055,0.00052266644,0.0024765916,0.000012380499,0.008032661,0.00010070937,0.068208314,0.0009975769,0.035764802,0.3151924],"study_design_scores_gemma":[0.013531407,0.005056493,0.38989127,0.00023390425,0.0022375,0.000026657068,0.006523613,0.003600268,0.015344668,0.00037273395,0.5628036,0.00037789484],"about_ca_topic_score_codex":0.0001045465,"about_ca_topic_score_gemma":0.000015267453,"teacher_disagreement_score":0.5270388,"about_ca_system_score_codex":0.000034816894,"about_ca_system_score_gemma":0.000118613214,"threshold_uncertainty_score":0.24201295},"labels":[],"label_agreement":null},{"id":"W2205484344","doi":"10.1080/19420862.2015.1098795","title":"A monoclonal antibody specific for prophase phosphorylation of histone deacetylase 1: a readout for early mitotic cells","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"IONICS Mass Spectrometry (Canada)","funders":"Associazione Italiana per la Ricerca sul Cancro; Fondazione Umberto Veronesi; Austrian Science Fund","keywords":"HDAC1; Monoclonal antibody; Prophase; Histone deacetylase; Histone; Mitosis; Phosphorylation; Biology; Cell biology; Serine; Histone deacetylase 5; Chemistry; Molecular biology; Biochemistry; Antibody; Genetics; DNA","score_opus":0.03474904819576767,"score_gpt":0.35044644965662447,"score_spread":0.3156974014608568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205484344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810154,0.0009313164,0.015930913,0.00016741088,0.00025439632,0.0012398233,0.0002048025,0.000014181666,0.00024179766],"genre_scores_gemma":[0.98377466,0.00002578195,0.008970313,0.000032092106,0.00042476848,0.00019418419,0.0005337247,0.000052042822,0.0059924535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987071,0.000038152484,0.00031311536,0.00039411712,0.00023546835,0.00031204568],"domain_scores_gemma":[0.998807,0.00002773626,0.00012779466,0.0003749266,0.00049355155,0.00016896793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037528088,0.00016174643,0.00021135126,0.00008762451,0.00006304514,0.00001828207,0.00017267799,0.00016062555,0.000010264815],"category_scores_gemma":[0.00016446986,0.0001485834,0.00015849402,0.000104060586,0.00012177397,0.000008859127,0.000052172352,0.00007001209,0.000016271346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001448051,0.00019800947,0.000059168564,0.00007559554,0.000027649734,0.0000029837784,0.00014064855,0.00006415245,0.96455204,0.00006352858,0.032415222,0.000952937],"study_design_scores_gemma":[0.0023836596,0.0011739115,0.00006209635,0.000019086026,0.00001690663,0.0000051102734,0.000041721873,0.00031770687,0.88860995,0.00006345283,0.107131675,0.00017472984],"about_ca_topic_score_codex":0.000032226028,"about_ca_topic_score_gemma":0.000008960555,"teacher_disagreement_score":0.075942114,"about_ca_system_score_codex":0.00008164457,"about_ca_system_score_gemma":0.00022642373,"threshold_uncertainty_score":0.6059055},"labels":[],"label_agreement":null},{"id":"W2275017004","doi":"10.1080/19420862.2015.1107687","title":"Multi-Site N-glycan mapping study 1: Capillary electrophoresis – laser induced fluorescence","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Capillary electrophoresis; Reproducibility; Glycan; Chromatography; Laser-induced fluorescence; Fluorescence; Chemistry; Bioanalysis; Reagent; Analytical Chemistry (journal); Biochemistry; Organic chemistry","score_opus":0.05151883728572046,"score_gpt":0.3005063829630543,"score_spread":0.24898754567733386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275017004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849397,0.00016013105,0.0001358192,0.00017999782,0.00008964994,0.0004870038,0.000006375734,0.000024693307,0.00042238104],"genre_scores_gemma":[0.99694574,0.000028551447,0.0008426405,0.00012902127,0.00014190662,0.000055510878,0.00007100625,0.000024379291,0.0017612169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986747,0.0001330618,0.0001744745,0.0003812691,0.00030298808,0.0003335323],"domain_scores_gemma":[0.99910015,0.0000053158997,0.0000445008,0.0004350826,0.00021269255,0.00020228174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003257779,0.00014749057,0.00012622461,0.00009188951,0.000092225535,0.0000469692,0.00022223388,0.00010993379,0.000037194517],"category_scores_gemma":[0.00020893398,0.00013752759,0.00004956758,0.00021635469,0.000031865737,0.0000049099845,0.00018089982,0.00014651904,0.00016060536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014382592,0.00021414373,0.019800814,0.000007650377,0.000036713547,0.000034941706,0.00029958872,0.000008722191,0.9727122,0.0000026460364,0.0032672817,0.0034714572],"study_design_scores_gemma":[0.0060327207,0.0023293265,0.09319482,0.000024640698,0.000022335016,0.000039302926,0.0021941087,0.0020830547,0.8042441,0.00002317617,0.088989936,0.00082249346],"about_ca_topic_score_codex":0.00030852167,"about_ca_topic_score_gemma":0.00035786795,"teacher_disagreement_score":0.16846813,"about_ca_system_score_codex":0.00003563196,"about_ca_system_score_gemma":0.0001370951,"threshold_uncertainty_score":0.56082124},"labels":[],"label_agreement":null},{"id":"W2285092458","doi":"10.1080/19420862.2015.1122150","title":"Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Protein purification and stability","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Lethbridge","keywords":"Chemistry; Chromatography; Mass spectrometry; Electrospray ionization; Size-exclusion chromatography; Critical quality attributes; Tandem mass spectrometry; Characterization (materials science); Electrospray; Liquid chromatography–mass spectrometry; Nanotechnology; Particle size; Biochemistry; Enzyme; Materials science","score_opus":0.011772013105947972,"score_gpt":0.24631361338885618,"score_spread":0.2345416002829082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2285092458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703949,0.0005006933,0.027211314,0.0006969594,0.00006953553,0.00069219194,0.00007490011,0.000020208134,0.0003392903],"genre_scores_gemma":[0.99749005,0.0000695784,0.0016621788,0.00026503947,0.00004382966,0.00006150798,0.00018120975,0.000013976395,0.0002126336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917555,0.000073300005,0.00019515713,0.00025431308,0.00016813427,0.00013353076],"domain_scores_gemma":[0.999324,0.0000062685185,0.00010362431,0.00029695852,0.000168332,0.00010081316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025267288,0.00010811945,0.0001297024,0.00005816475,0.000036208166,0.000012206868,0.0001418939,0.000098734876,0.00007391068],"category_scores_gemma":[0.00011697046,0.00010134836,0.000053830994,0.0002788341,0.000054265736,0.000004523722,0.000042209977,0.00004357395,0.000011259488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001215617,0.00009636808,0.0007971879,0.000016737298,0.00002246019,1.4503084e-7,0.00007954492,3.6383986e-7,0.9978552,0.000044344637,0.000118466276,0.0008476344],"study_design_scores_gemma":[0.00051513844,0.00036560558,0.008447563,0.000008062267,0.0000057319107,9.3998324e-7,0.000040574367,0.00005511842,0.9665589,0.00010495508,0.023764275,0.000133161],"about_ca_topic_score_codex":0.000009978886,"about_ca_topic_score_gemma":0.0000019004316,"teacher_disagreement_score":0.03129631,"about_ca_system_score_codex":0.000021970056,"about_ca_system_score_gemma":0.000055044027,"threshold_uncertainty_score":0.41328663},"labels":[],"label_agreement":null},{"id":"W2317616246","doi":"10.4161/mabs.22287","title":"<i>FCGR2C</i>genotyping by pyrosequencing reveals linkage disequilibrium with<i>FCGR3A</i>V158F and<i>FCGR2A</i>H131R polymorphisms in a Caucasian population","year":2012,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Linkage disequilibrium; Genotyping; Genotype; Allele; Biology; Genetics; Polymorphism (computer science); Population; Molecular biology; Haplotype; Gene; Medicine","score_opus":0.012251827649632258,"score_gpt":0.26815386862272156,"score_spread":0.25590204097308933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317616246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846565,0.0069207866,0.000065832675,0.004225854,0.00014155361,0.0005969825,0.000049587743,0.00008632721,0.0032565675],"genre_scores_gemma":[0.9929586,0.00020751375,0.0008515771,0.0013555314,0.000406087,0.000046772253,0.00022248903,0.00006686563,0.0038845378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733096,0.0001333496,0.00049678126,0.00045747304,0.00058115076,0.0010002961],"domain_scores_gemma":[0.998765,0.00012970813,0.00012092238,0.00035810051,0.00007339944,0.00055287586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005985475,0.00034213281,0.0005391661,0.00024867838,0.00016384639,0.000055516233,0.00013242138,0.00016774832,0.00013963855],"category_scores_gemma":[0.000104020044,0.00027339326,0.00009085401,0.00046099274,0.00015772347,0.00039841392,0.0001277163,0.00050562376,0.0000623614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005480856,0.00017819022,0.83533597,0.00029497498,0.000049809943,0.00012572881,0.00085040793,0.0000027442027,0.15658449,0.0011686542,0.001451265,0.0034097123],"study_design_scores_gemma":[0.0020995284,0.00040473707,0.9764549,0.000890541,0.0000928507,0.0006279208,0.00018936282,0.00032461534,0.0074408916,0.0004807381,0.0103155365,0.00067837327],"about_ca_topic_score_codex":0.0025423893,"about_ca_topic_score_gemma":0.00014644484,"teacher_disagreement_score":0.14914359,"about_ca_system_score_codex":0.00017879246,"about_ca_system_score_gemma":0.000064813816,"threshold_uncertainty_score":0.9999718},"labels":[],"label_agreement":null},{"id":"W2328817553","doi":"10.4161/mabs.29262","title":"MAbImprove","year":2014,"lang":"pt","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"","keywords":"Excellence; Government (linguistics); Context (archaeology); Library science; General partnership; Political science; Sociology; Public relations; Business; Computer science; Finance","score_opus":0.02290199610372964,"score_gpt":0.31106121662376696,"score_spread":0.28815922052003734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328817553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6472641,0.004699214,0.0007403269,0.034007326,0.00253318,0.00077292445,0.00008177772,0.0001329874,0.3097681],"genre_scores_gemma":[0.7381498,0.00016391512,0.00010337659,0.0017431825,0.0015652654,0.000009493642,0.000031613366,0.000029352104,0.25820398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803644,0.00011446488,0.00028931187,0.00036415874,0.000565773,0.00062985066],"domain_scores_gemma":[0.99879986,0.00019263056,0.000057586167,0.00042315666,0.00013350658,0.00039327607],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00044758455,0.00022481776,0.00036522798,0.00010964769,0.00014554134,0.000044056913,0.00021623094,0.00015762969,0.0037572882],"category_scores_gemma":[0.0002538215,0.00017765342,0.00017563233,0.00018334239,0.00015610363,0.00004653473,0.00018229178,0.0004595451,0.0103612775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023791678,0.0010529569,0.14304589,0.0031937915,0.0006360046,0.0004051921,0.0015088686,0.0000067529163,0.031884212,0.06033291,0.28306338,0.47249088],"study_design_scores_gemma":[0.0015966066,0.0012583408,0.06907086,0.00027613368,0.000099707475,0.000069663314,0.000228711,0.005566571,0.0028823311,0.00069398835,0.91790724,0.0003498563],"about_ca_topic_score_codex":0.00029081406,"about_ca_topic_score_gemma":0.00002352299,"teacher_disagreement_score":0.6348438,"about_ca_system_score_codex":0.000049554154,"about_ca_system_score_gemma":0.000089506306,"threshold_uncertainty_score":0.9971534},"labels":[],"label_agreement":null},{"id":"W2402884563","doi":"10.1080/19420862.2016.1186320","title":"Development and characterization of synthetic antibodies binding to the cystic fibrosis conductance regulator","year":2016,"lang":"en","type":"article","venue":"mAbs","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"Cystic fibrosis transmembrane conductance regulator; Cystic fibrosis; Chloride channel; Epitope; Chemistry; Antibody; Western blot; Binding site; Phage display; Molecular biology; Biochemistry; Peptide; Biology; Immunology; Genetics","score_opus":0.018778002931898775,"score_gpt":0.2784342465735983,"score_spread":0.2596562436416995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402884563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995194,0.00009740254,0.0013296974,0.0029593005,0.000057483776,0.0002783433,0.000021001122,0.000017421893,0.000045339722],"genre_scores_gemma":[0.99094325,0.000036476635,0.007972055,0.00003930983,0.000030726034,0.000022878432,0.000006021378,0.000010143247,0.00093914935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927354,0.000020612044,0.00017096351,0.00015586807,0.00022265704,0.00015635962],"domain_scores_gemma":[0.99948895,0.00013113087,0.0000521493,0.00017866837,0.000077600904,0.00007151211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016469246,0.000073642914,0.00015033373,0.00007307783,0.000065841195,0.000011166345,0.00005963985,0.00001998693,0.000054187592],"category_scores_gemma":[0.00041380193,0.000037785776,0.000014832329,0.00012660249,0.00009269119,0.000062497646,0.000059020964,0.000028092622,0.000040083425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009682952,0.000010724958,0.0028976963,0.00010642599,0.000013548663,0.0000015596844,0.00027645135,9.389111e-8,0.96997994,0.00015894021,0.00004918968,0.026408583],"study_design_scores_gemma":[0.000400531,0.00011542698,0.2817094,0.0012057251,0.00001696583,0.000021187758,0.000106614374,0.00001823562,0.69103014,0.00003277888,0.02525195,0.000091034824],"about_ca_topic_score_codex":0.000001555707,"about_ca_topic_score_gemma":0.0000030055478,"teacher_disagreement_score":0.27894983,"about_ca_system_score_codex":0.000043375425,"about_ca_system_score_gemma":0.000044491222,"threshold_uncertainty_score":0.15408592},"labels":[],"label_agreement":null},{"id":"W2547090396","doi":"10.1080/19420862.2016.1255389","title":"Development and preclinical studies of <sup>64</sup>Cu-NOTA-pertuzumab F(ab′)<sub>2</sub> for imaging changes in tumor HER2 expression associated with response to trastuzumab by PET/CT","year":2016,"lang":"en","type":"article","venue":"mAbs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Pertuzumab; Trastuzumab; Biodistribution; Medicine; Nuclear medicine; Breast cancer; Cancer; Cancer research; Chemistry; Internal medicine; Biochemistry; In vitro","score_opus":0.06149780428111189,"score_gpt":0.37061000100646496,"score_spread":0.30911219672535306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547090396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905343,0.0009556621,0.00006721355,0.0068686325,0.00004452023,0.0013733386,0.00007221239,0.00005644686,0.00002769082],"genre_scores_gemma":[0.99669707,0.00015823358,0.0015048936,0.00036675204,0.00005068564,0.0007021756,0.000012733493,0.00006754955,0.00043990853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972344,0.00028892246,0.00056405197,0.0006187563,0.00066842145,0.00062544225],"domain_scores_gemma":[0.99702454,0.0019268477,0.00014340121,0.0003304055,0.0003209554,0.0002538341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002064373,0.0002802696,0.00071736745,0.00026936238,0.00010608615,0.000019433905,0.00016168432,0.000028537886,0.000026287085],"category_scores_gemma":[0.004089165,0.00018023449,0.00005004481,0.00028820848,0.00021494356,0.00008651273,0.00018437362,0.00020686496,0.00000841053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021942327,0.0008380682,0.038992476,0.0007917294,0.0003617826,0.00079118006,0.0064181895,0.000006782809,0.8004961,0.000005277145,0.022847317,0.10650876],"study_design_scores_gemma":[0.013340184,0.0028053683,0.041888203,0.008636273,0.00008707557,0.00015597018,0.0042401897,0.00022163722,0.9119188,0.00003345235,0.016077714,0.00059513754],"about_ca_topic_score_codex":0.000020707008,"about_ca_topic_score_gemma":0.00021890392,"teacher_disagreement_score":0.11142269,"about_ca_system_score_codex":0.0008689192,"about_ca_system_score_gemma":0.00049117283,"threshold_uncertainty_score":0.7349749},"labels":[],"label_agreement":null},{"id":"W2757236411","doi":"10.1080/19420862.2017.1379641","title":"Suppressing allostery in epitope mapping experiments using millisecond hydrogen / deuterium exchange mass spectrometry","year":2017,"lang":"en","type":"article","venue":"mAbs","topic":"Mass Spectrometry Techniques and Applications","field":"Chemistry","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Epitope; Hydrogen–deuterium exchange; Epitope mapping; Chemistry; Myoglobin; Allosteric regulation; Millisecond; Mass spectrometry; Biological system; Biochemistry; Antigen; Enzyme; Chromatography; Physics; Biology","score_opus":0.050615139454197454,"score_gpt":0.30917017285902654,"score_spread":0.2585550334048291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757236411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95867676,0.0005750227,0.0007029616,0.00021305383,0.00007833903,0.00013584833,0.000043607626,0.00009163917,0.039482802],"genre_scores_gemma":[0.9804102,0.00008296381,0.01814373,0.000060382612,0.00026254222,0.000072505005,0.000032122523,0.000046269855,0.00088927586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985519,0.000014621931,0.00032304018,0.0004531156,0.00019361805,0.00046371185],"domain_scores_gemma":[0.9985544,0.000021322532,0.00024047337,0.0010610764,0.000023733306,0.00009896285],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014178445,0.00022670496,0.0002798086,0.0001819562,0.00034723512,0.00026649924,0.00063897506,0.00015534417,0.004823222],"category_scores_gemma":[0.000026200581,0.0002519522,0.00009669359,0.0001120971,0.00007113523,0.00027850037,0.00031742622,0.00022824176,0.000021143715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006548452,0.000052574556,0.011798834,0.000096697964,0.000019640314,0.000037934416,0.00011678834,0.0000012777499,0.986749,0.000092516406,0.00009994374,0.00092822633],"study_design_scores_gemma":[0.00045521115,0.000009300813,0.00214716,0.00016689902,0.000011418247,0.000023202672,0.0001878878,0.0009324002,0.9859096,0.0013867199,0.008401302,0.00036892874],"about_ca_topic_score_codex":0.00016979173,"about_ca_topic_score_gemma":0.000011634064,"teacher_disagreement_score":0.038593523,"about_ca_system_score_codex":0.0002227865,"about_ca_system_score_gemma":0.000020015577,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W2809145153","doi":"10.1080/19420862.2018.1489633","title":"Antigen recognition by single-domain antibodies: structural latitudes and constraints","year":2018,"lang":"en","type":"review","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; National Research Council Canada","funders":"National Research Council Canada","keywords":"Paratope; Single-domain antibody; Epitope; Antibody; Antigen; Computational biology; Biology; Genetics","score_opus":0.10112187569183595,"score_gpt":0.3791820976101544,"score_spread":0.2780602219183185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809145153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062968703,0.9864152,0.000007533055,0.00014516288,0.00018019247,0.00074139965,0.00066662923,0.00004926058,0.005497724],"genre_scores_gemma":[0.00025392536,0.99479324,0.0010745667,0.00011155773,0.00051868317,0.000017253933,0.001605254,0.000048185553,0.0015773426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807084,0.00013071869,0.0004884663,0.0005016066,0.00038119438,0.00042716597],"domain_scores_gemma":[0.9990485,0.00017764886,0.00017405114,0.00022751054,0.00013540177,0.0002369388],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022642904,0.000412394,0.0012796255,0.00017101917,0.00016886467,0.00007283777,0.00012747633,0.0003053272,0.0010849059],"category_scores_gemma":[0.000097718366,0.00028961003,0.00025924746,0.00016254096,0.00089723675,0.00006527452,0.00013119909,0.000400654,0.0003179652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043410324,0.000039132792,0.0002543164,0.011623861,0.0003392672,0.00007963038,0.000067351175,6.147352e-10,0.00007092963,0.000054642092,0.009440187,0.9779873],"study_design_scores_gemma":[0.00032600184,0.0002875243,0.00012259906,0.009590747,0.00018521519,0.0006895495,0.000029688195,0.0000014744764,0.000024174758,0.0003550084,0.98806,0.00032804892],"about_ca_topic_score_codex":0.000047136306,"about_ca_topic_score_gemma":0.000010603887,"teacher_disagreement_score":0.97861975,"about_ca_system_score_codex":0.000063977765,"about_ca_system_score_gemma":0.00013671571,"threshold_uncertainty_score":0.9999556},"labels":[],"label_agreement":null},{"id":"W2810290100","doi":"10.1080/19420862.2018.1494107","title":"The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities","year":2018,"lang":"en","type":"article","venue":"mAbs","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; University of British Columbia","funders":"National Health and Medical Research Council","keywords":"Antibody; Epitope; Monoclonal antibody; Humanized antibody; Granulocyte macrophage colony-stimulating factor; Hematopoietic growth factor; Cytokine; Immunology; Biology; Haematopoiesis; Cell biology","score_opus":0.07240366739069344,"score_gpt":0.33657185208347706,"score_spread":0.26416818469278364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810290100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96386355,0.00086260383,0.0014486272,0.007235674,0.00025018028,0.00079672976,0.0000552859,0.00014572359,0.025341596],"genre_scores_gemma":[0.9806661,0.00029196072,0.00012609006,0.00069468387,0.00015467306,0.000027441314,0.000074554606,0.00004365557,0.017920818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998187,0.000086757645,0.00036852047,0.00026835938,0.0006957221,0.0003936399],"domain_scores_gemma":[0.9986112,0.0001335151,0.00013006103,0.00052529963,0.00046903486,0.00013090057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054541836,0.00018699,0.0002736635,0.00014623764,0.00036936696,0.000057855646,0.00018268218,0.00011962135,0.0006526071],"category_scores_gemma":[0.00010098873,0.00013034328,0.00010825653,0.00016152246,0.0005607688,0.000078947836,0.00015765657,0.00024164704,0.000115145485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001008618,0.00017393423,0.00017476814,0.000092039816,0.000073709685,0.000019291894,0.00040747496,5.804681e-8,0.9591337,0.023586461,0.010406934,0.0058308067],"study_design_scores_gemma":[0.0020252774,0.0014944951,0.0049843625,0.00025507144,0.00010946139,0.000066410576,0.0017383724,0.0004261267,0.9139137,0.0060532005,0.06863643,0.00029705366],"about_ca_topic_score_codex":0.00014934904,"about_ca_topic_score_gemma":0.00006371332,"teacher_disagreement_score":0.058229495,"about_ca_system_score_codex":0.00006760184,"about_ca_system_score_gemma":0.00011597499,"threshold_uncertainty_score":0.714559},"labels":[],"label_agreement":null},{"id":"W2891096931","doi":"10.1080/19420862.2018.1515565","title":"A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties","year":2018,"lang":"en","type":"article","venue":"mAbs","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Advanced Research; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation; Ontario Ministry of Research, Innovation and Science; Canadian Cancer Society; Genome Canada","keywords":"Frizzled; Wnt signaling pathway; Monoclonal antibody; Antibody; Phage display; Receptor; Cancer research; Ligand (biochemistry); Chemistry; Cell; Cell biology; Biology; Molecular biology; Signal transduction; Biochemistry; Immunology","score_opus":0.01508810934813716,"score_gpt":0.24977441593438143,"score_spread":0.2346863065862443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891096931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843041,0.000628869,0.01326842,0.0001536985,0.0005450137,0.00047873956,0.000015939613,0.000053703345,0.00055154436],"genre_scores_gemma":[0.9955106,0.000069008565,0.0012155769,0.00017313547,0.0007624949,0.00009400912,0.00009710735,0.000047970505,0.0020301451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986199,0.00002992854,0.0002752985,0.00051105896,0.00015802357,0.00040575457],"domain_scores_gemma":[0.9992195,0.00001019229,0.00009005567,0.00034894145,0.0002574783,0.00007382832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018742791,0.00024144627,0.00025323272,0.000055945115,0.00015861102,0.000052145475,0.00027328447,0.00012798986,0.00011299981],"category_scores_gemma":[0.00011303589,0.00020968671,0.00011376565,0.00011617419,0.00014956798,0.0000068266436,0.000090908674,0.00006216603,0.00005779644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016427723,0.0000507903,0.00023630797,0.00005472405,0.00006167508,0.0000019049289,0.000093999304,0.000027479395,0.99722505,0.000023366252,0.0016887365,0.00037171072],"study_design_scores_gemma":[0.00076787185,0.00023106292,0.0013403498,0.00007701206,0.000023076185,0.000009183824,0.000048596303,0.00019898158,0.97520155,0.000030750703,0.021727644,0.00034390867],"about_ca_topic_score_codex":0.0000059662666,"about_ca_topic_score_gemma":0.0000052867354,"teacher_disagreement_score":0.022023465,"about_ca_system_score_codex":0.000019583598,"about_ca_system_score_gemma":0.00009538129,"threshold_uncertainty_score":0.8550776},"labels":[],"label_agreement":null},{"id":"W2906321352","doi":"10.1080/19420862.2018.1544454","title":"Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics","year":2018,"lang":"en","type":"article","venue":"mAbs","topic":"Protein purification and stability","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Health Canada","funders":"Pacific Northwest National Laboratory; National Health and Medical Research Council; Biological and Environmental Research; Health Canada; Office of Science; National Institute of Standards and Technology; Stockholms Universitet; Knut och Alice Wallenbergs Stiftelse; Eidgenössische Technische Hochschule Zürich; Ministério da Ciência, Tecnologia, Inovações e Comunicações; Government of Canada; Ministry of Education, Culture, Sports, Science and Technology; Medical University of South Carolina; Medical Research Council; Biogen; U.S. Department of Energy; W. M. Keck Foundation; University of South Carolina","keywords":"Comparability; Biopharmaceutical; NIST; Consistency (knowledge bases); Computer science; Process analytical technology; Quality assurance; Biochemical engineering; Mathematics; Artificial intelligence; Engineering; Biotechnology; Biology; External quality assessment","score_opus":0.024400211407979353,"score_gpt":0.3409356002883238,"score_spread":0.31653538888034444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906321352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9301973,0.00086917594,0.06740399,0.00056521915,0.0001778915,0.0004025817,0.000085993815,0.000004965673,0.00029287284],"genre_scores_gemma":[0.9950006,0.000055147215,0.004502618,0.000108265456,0.0001271422,0.000010223353,0.00008409303,0.000005928254,0.0001059982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995688,0.000025277173,0.0001379091,0.00011881148,0.00007632604,0.00007284487],"domain_scores_gemma":[0.999357,0.000013983565,0.000089066045,0.00025360569,0.00027505722,0.000011314411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014371061,0.000055307362,0.00006677195,0.000010239128,0.00004646237,0.0000052286127,0.00010850845,0.00007207963,0.000052513424],"category_scores_gemma":[0.000016471025,0.000037425256,0.000040574498,0.000049420076,0.00010554966,0.000001607603,0.000025939797,0.000033606786,2.6362758e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055422297,0.00003640905,0.0031869144,0.000022820379,0.000046027,1.1883285e-8,0.00002613666,0.000023131754,0.99028945,0.0020139595,0.00003786946,0.0042618215],"study_design_scores_gemma":[0.0006963102,0.00045301003,0.15751751,0.000009268583,0.000051066832,9.5159356e-7,0.00009632969,0.001716514,0.6957097,0.0014343908,0.1421817,0.0001332585],"about_ca_topic_score_codex":0.0000060924417,"about_ca_topic_score_gemma":0.0000059353138,"teacher_disagreement_score":0.29457977,"about_ca_system_score_codex":0.000004990628,"about_ca_system_score_gemma":0.000049628743,"threshold_uncertainty_score":0.15261576},"labels":[],"label_agreement":null},{"id":"W2919517942","doi":"10.1080/19420862.2019.1581017","title":"Impact of N-glycosylation on Fcγ receptor / IgG interactions: unravelling differences with an enhanced surface plasmon resonance biosensor assay based on coiled-coil interactions","year":2019,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Polytechnique Montréal; National Research Council Canada","funders":"National Research Council Canada; Servier; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Surface plasmon resonance; Glycosylation; Biosensor; Chemistry; Receptor–ligand kinetics; Immunoglobulin G; Fc receptor; Biophysics; Receptor; Fragment crystallizable region; Biochemistry; Antibody; Biology; Nanotechnology; Materials science; Immunology","score_opus":0.02898577292644913,"score_gpt":0.33465054260399313,"score_spread":0.305664769677544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919517942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932916,0.00002864423,0.00021437882,0.00060942874,0.00025061806,0.00043677643,0.00010186257,0.000045536737,0.0050211414],"genre_scores_gemma":[0.9928516,0.000063920954,0.00078929105,0.000096445074,0.000103864724,0.0000141961045,0.00016026222,0.000029101315,0.005891303],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982694,0.0001589069,0.0003213465,0.00040474566,0.0005526567,0.00029297452],"domain_scores_gemma":[0.9981853,0.0008226028,0.00018629838,0.00037736454,0.00027296037,0.00015548796],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021031042,0.00024009011,0.00038210125,0.0002111258,0.000106400425,0.000032998356,0.00011682107,0.000071597606,0.0014021473],"category_scores_gemma":[0.00011797666,0.00015956027,0.00013949271,0.0003058034,0.000076797856,0.00016607478,0.00001779695,0.00046863878,0.00034242397],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051698893,0.0029423411,0.2750685,0.00038723103,0.00035607943,0.0000290167,0.0010480337,0.010505732,0.6247153,0.00046468893,0.0010149553,0.031769216],"study_design_scores_gemma":[0.003717985,0.015928444,0.5257127,0.0032520348,0.00006990604,0.00002438977,0.00039355023,0.114006944,0.3309042,0.00004707152,0.0053427075,0.0006000362],"about_ca_topic_score_codex":0.00065256277,"about_ca_topic_score_gemma":0.00017682425,"teacher_disagreement_score":0.2938111,"about_ca_system_score_codex":0.00018107734,"about_ca_system_score_gemma":0.00014272258,"threshold_uncertainty_score":0.9995107},"labels":[],"label_agreement":null},{"id":"W2923713236","doi":"10.1080/19420862.2019.1595307","title":"Detection and quantification of free sulfhydryls in monoclonal antibodies using maleimide labeling and mass spectrometry","year":2019,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Chemistry; Maleimide; Cysteine; Chromatography; Mass spectrometry; Reagent; Monoclonal antibody; Biochemistry; Antibody; Enzyme; Organic chemistry","score_opus":0.03446249204436033,"score_gpt":0.3091059037930905,"score_spread":0.2746434117487302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923713236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692047,0.0017361993,0.00022494819,0.0003847776,0.000060602986,0.00022435929,0.000013788001,0.000010846001,0.00042402072],"genre_scores_gemma":[0.9942735,0.0005196655,0.004784199,0.000026908745,0.00004675755,0.0000019629756,0.000008149216,0.000011061246,0.00032783643],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991009,0.000033349068,0.00023464879,0.00022397368,0.00021963827,0.00018744158],"domain_scores_gemma":[0.99955535,0.000094197836,0.0000624654,0.00016577783,0.000062939995,0.0000592464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027812916,0.00009973013,0.00024876645,0.00028195337,0.000039089617,0.0000152572,0.00004782824,0.00006786072,0.00005513539],"category_scores_gemma":[0.00007754575,0.000087517794,0.00003004794,0.00020873436,0.00008662536,0.00008310346,0.00006532066,0.00016607028,0.000005449343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019748829,0.000020123562,0.36139703,0.00024137234,0.000016481838,0.0000068834806,0.00005138051,0.000012031771,0.63684,0.00020159036,0.000002636618,0.0010130109],"study_design_scores_gemma":[0.0012579446,0.00025252675,0.7445538,0.0002487808,0.000030524483,0.00010289648,0.00021011427,0.021167174,0.23081505,0.0010444892,0.00016955237,0.00014712854],"about_ca_topic_score_codex":0.00048265973,"about_ca_topic_score_gemma":0.000060093116,"teacher_disagreement_score":0.40602493,"about_ca_system_score_codex":0.000029756688,"about_ca_system_score_gemma":0.000024391025,"threshold_uncertainty_score":0.3568872},"labels":[],"label_agreement":null},{"id":"W2950057276","doi":"10.1080/19420862.2019.1624126","title":"Rapid single B cell antibody discovery using nanopens and structured light","year":2019,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Amgen (Canada)","funders":"Scheme for Promotion of Academic and Research Collaboration; Amgen","keywords":"Antibody; Monoclonal antibody; Drug discovery; Immunoglobulin light chain; Antigen; Molecular biology; Phage display; B cell; Immunoassay; Chemistry; Recombinant DNA; Immunization; Computational biology; Biology; Immunology; Biochemistry","score_opus":0.023500265097913597,"score_gpt":0.2935686493296544,"score_spread":0.2700683842317408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950057276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433936,0.0016966374,0.000015714195,0.0009008909,0.00020660966,0.00026856494,0.000016991562,0.000018472092,0.012536773],"genre_scores_gemma":[0.98033625,0.00014900077,0.0005027458,0.0003142618,0.0001666039,9.3259433e-7,0.00003795111,0.000019788007,0.018472455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990237,0.000028168473,0.00014743776,0.00025155547,0.00026729796,0.0002818743],"domain_scores_gemma":[0.99955004,0.00003845526,0.00003746264,0.00020528035,0.000046961617,0.00012178391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008064076,0.00013199267,0.00024710578,0.00007968275,0.00007386716,0.00006055916,0.000067552864,0.00006779792,0.0005812441],"category_scores_gemma":[0.000012964936,0.00009466433,0.00006304459,0.00010826306,0.000054627282,0.00013156747,0.000116203235,0.0001575589,0.000102825936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002325863,0.000062971354,0.036387216,0.0002107861,0.000026194106,0.000053667598,0.000111601854,0.0000014651947,0.96096617,0.00016201861,0.00043314238,0.00135218],"study_design_scores_gemma":[0.0035857742,0.0013698415,0.14384475,0.00037303191,0.00011283335,0.0004513899,0.0003516322,0.001208326,0.6031251,0.0003667465,0.24462056,0.00059001223],"about_ca_topic_score_codex":0.000098394354,"about_ca_topic_score_gemma":0.0000053515278,"teacher_disagreement_score":0.35784107,"about_ca_system_score_codex":0.000027088478,"about_ca_system_score_gemma":0.00005148831,"threshold_uncertainty_score":0.63642156},"labels":[],"label_agreement":null},{"id":"W2963889829","doi":"10.1080/19420862.2019.1632114","title":"Binding symmetry and surface flexibility mediate antibody self-association","year":2019,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; National Research Council Canada","funders":"National Research Council Canada; Western Economic Diversification Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; National Research Foundation; Canadian Light Source","keywords":"Chemistry; Protein engineering; In silico; Monoclonal antibody; Docking (animal); Protein Data Bank (RCSB PDB); Hydrophobic effect; Computational biology; Monomer; Protein structure; Biophysics; Crystallography; Antibody; Stereochemistry; Biochemistry; Biology; Genetics; Enzyme","score_opus":0.01440212094633236,"score_gpt":0.3183102044220189,"score_spread":0.30390808347568654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963889829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897754,0.00035938303,0.0000022708732,0.002012991,0.00019338944,0.00026616722,0.000020281814,0.00006662916,0.0073034815],"genre_scores_gemma":[0.9866057,0.00025319608,0.00039245936,0.0002556154,0.00010452322,0.0000014330819,0.00005306793,0.000011978443,0.012322032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882495,0.00005475614,0.00016545113,0.0002458619,0.0004197657,0.00028920392],"domain_scores_gemma":[0.99935025,0.00020293763,0.00005637493,0.00016071838,0.000091154696,0.00013858557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058732025,0.000102703394,0.0002309943,0.000059090293,0.00006777927,0.000025460582,0.000053559903,0.00009860786,0.00030005293],"category_scores_gemma":[0.00009942348,0.00008144981,0.000055555538,0.00017265113,0.00001998678,0.00007037282,0.00008186972,0.00022309819,0.00070051453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010399247,0.00006588201,0.9467177,0.00023274313,0.00006890781,0.000011500374,0.00013568962,7.007701e-7,0.051262558,0.00035413742,0.0004763674,0.0005698536],"study_design_scores_gemma":[0.0014463321,0.00030032068,0.95721906,0.00008092837,0.00005384386,0.000027495791,0.00012735622,0.0014004533,0.010747126,0.0002574639,0.028138934,0.00020069243],"about_ca_topic_score_codex":0.00012460232,"about_ca_topic_score_gemma":0.0000043193468,"teacher_disagreement_score":0.04051543,"about_ca_system_score_codex":0.00012709823,"about_ca_system_score_gemma":0.000053758347,"threshold_uncertainty_score":0.90039307},"labels":[],"label_agreement":null},{"id":"W2990699742","doi":"10.1080/19420862.2019.1682866","title":"Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment","year":2019,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"JavaScript; Zoom; Computer science; Feature (linguistics); Click chemistry; Chemistry; Antibody; Computational biology; Combinatorial chemistry; Programming language; Physics; Biology; Immunology; Optics","score_opus":0.009002226612945561,"score_gpt":0.2833566568706805,"score_spread":0.2743544302577349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990699742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982309,0.00019693363,0.0004984976,0.00013529714,0.00009693993,0.00055502215,0.00018744856,0.000010263563,0.00008870212],"genre_scores_gemma":[0.99610734,0.000010060806,0.003218923,0.000039465758,0.00006855355,0.0000074652353,0.00009109078,0.000022031785,0.00043504755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894726,0.00001401969,0.0002793509,0.00019253588,0.00029926162,0.00026758245],"domain_scores_gemma":[0.99949473,0.00011928764,0.000111676076,0.00013094944,0.000075985576,0.00006739152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016071259,0.00012450905,0.00034420265,0.00013549,0.00002656866,0.000003200989,0.000084472646,0.000042164695,0.00017961209],"category_scores_gemma":[0.000056192584,0.0001021366,0.00012008632,0.0000964583,0.000032010845,0.000025356441,0.00004376881,0.00013286987,0.00001048717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041174403,0.00006572168,0.034096498,0.00090775645,0.00008979874,0.0000052772425,0.00007901101,0.00085144734,0.9631732,0.000060402715,0.000094837225,0.00016426612],"study_design_scores_gemma":[0.0012616145,0.0004828287,0.020328695,0.00018457216,0.000036309448,0.000008167446,0.00006557061,0.0059605227,0.97057,0.000014922205,0.0009844581,0.00010229893],"about_ca_topic_score_codex":0.000045999357,"about_ca_topic_score_gemma":0.0000013255103,"teacher_disagreement_score":0.013767804,"about_ca_system_score_codex":0.000060113663,"about_ca_system_score_gemma":0.000057216916,"threshold_uncertainty_score":0.41650096},"labels":[],"label_agreement":null},{"id":"W3000081647","doi":"10.1080/19420862.2019.1709322","title":"VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis","year":2020,"lang":"en","type":"article","venue":"mAbs","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Monoclonal antibody; Chemokine; Antagonist; Chemokine receptor; Inflammation; Pharmacology; Antibody; CX3CR1; Dosing; CCR5 receptor antagonist; Medicine; Immunology; Receptor; Internal medicine","score_opus":0.024584334972121757,"score_gpt":0.2955950948267394,"score_spread":0.27101075985461764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000081647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988418,0.00056092744,0.00017694544,0.009472065,0.000104566694,0.00033247937,0.000006717977,0.00007277987,0.0008555586],"genre_scores_gemma":[0.99726045,0.0001477962,0.0011868367,0.0006311817,0.0005592656,0.00000897736,0.000059707705,0.000032258038,0.00011351244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888384,0.000031149953,0.00032590915,0.00023029906,0.00032468437,0.0002041068],"domain_scores_gemma":[0.99940795,0.00005043753,0.00014417231,0.00016732192,0.00011126468,0.00011884314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002371124,0.00014339153,0.00030200413,0.00002379931,0.000081759266,0.000014308856,0.0001072387,0.00008098153,0.000718118],"category_scores_gemma":[0.0002317617,0.00008794993,0.00013183626,0.0003121551,0.000067791225,0.000041363633,0.00009283668,0.00021795963,0.00003796288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009346067,0.000070168964,0.019095877,0.00018189418,0.000026975611,9.197078e-7,0.0008529537,0.0000028230927,0.9685293,0.000026605514,0.0045000883,0.006618949],"study_design_scores_gemma":[0.0009808763,0.00025801544,0.0018184074,0.00043169703,0.00004791468,0.0000027689964,0.00032073987,0.00051177497,0.9678355,0.0000070691926,0.027669402,0.000115819144],"about_ca_topic_score_codex":0.000009601635,"about_ca_topic_score_gemma":1.892337e-7,"teacher_disagreement_score":0.023169313,"about_ca_system_score_codex":0.00002190989,"about_ca_system_score_gemma":0.000035349174,"threshold_uncertainty_score":0.7862888},"labels":[],"label_agreement":null},{"id":"W3001156896","doi":"10.1080/19420862.2020.1717265","title":"<i>In situ</i> antibody phage display yields optimal inhibitors of integrin α11/β1","year":2020,"lang":"en","type":"article","venue":"mAbs","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Integrin; Antibody; Phage display; Transmembrane protein; Biology; Molecular biology; Extracellular matrix; Antigen; Cell; Collagen receptor; Cell biology; Chemistry; Receptor; Biochemistry; Immunology","score_opus":0.020275832003050897,"score_gpt":0.3198966317178055,"score_spread":0.29962079971475464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001156896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817093,0.00020740282,0.0003001586,0.0071073477,0.000081626924,0.0003054168,0.0000065735426,0.000029209756,0.010252952],"genre_scores_gemma":[0.9972397,0.000059524304,0.00055384793,0.00095320883,0.00015595957,0.0000066611806,0.000027309517,0.00002475522,0.0009790512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866396,0.00004914426,0.00031345547,0.0002760299,0.00042991582,0.00026751563],"domain_scores_gemma":[0.9993813,0.000064890286,0.00004649621,0.00023141033,0.00006139961,0.00021450134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016963507,0.00012903636,0.00031007672,0.000118249794,0.000017692237,0.000010143469,0.00014395715,0.00010449626,0.0006566329],"category_scores_gemma":[0.00024008813,0.0001089392,0.000105809035,0.00042293337,0.00007801716,0.000060754362,0.00016927096,0.00045160807,0.00023429755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032510908,0.0001618971,0.005908298,0.00020640565,0.000016098658,0.0005692722,0.0005910998,0.00001423157,0.9844648,0.0001371298,0.006586569,0.0010190541],"study_design_scores_gemma":[0.0026977295,0.00092779123,0.010136228,0.0002194754,0.000031251664,0.00003181384,0.0006245482,0.0018821085,0.9656958,0.000019672885,0.017528178,0.00020537642],"about_ca_topic_score_codex":0.000065920416,"about_ca_topic_score_gemma":0.000010190062,"teacher_disagreement_score":0.018769009,"about_ca_system_score_codex":0.000038066846,"about_ca_system_score_gemma":0.000077874254,"threshold_uncertainty_score":0.71896696},"labels":[],"label_agreement":null},{"id":"W3013411029","doi":"10.1080/19420862.2020.1742457","title":"Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors","year":2020,"lang":"en","type":"article","venue":"mAbs","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Virology; Ebola virus; Ebolavirus; Monoclonal antibody; Antibody; Epitope; Neutralization; Biology; Virus; Immunology","score_opus":0.041466116414532364,"score_gpt":0.30159430425408146,"score_spread":0.2601281878395491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013411029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99039245,0.00042373218,0.00041229092,0.005297095,0.0001244506,0.00024069114,0.000045560493,0.00019542838,0.0028682894],"genre_scores_gemma":[0.99657387,0.00039918217,0.00023609109,0.0020394765,0.00024926904,0.000008129952,0.00013921235,0.000027754868,0.00032701023],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989031,0.000046218716,0.00024118376,0.00029799706,0.00020446314,0.00030705341],"domain_scores_gemma":[0.999394,0.00002998148,0.000042134983,0.0001580307,0.00011599142,0.0002598625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067030436,0.00015696768,0.00027024487,0.000093155155,0.00014962691,0.000058008845,0.00008435543,0.00010150967,0.00045124168],"category_scores_gemma":[0.000050161914,0.00013105653,0.00012481735,0.00032402785,0.000031075175,0.00009646677,0.0000940243,0.00036318856,0.00038869772],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006651452,0.00019588659,0.042328283,0.00007592552,0.00030509604,0.00047796193,0.0006792166,0.00018604047,0.92469865,0.00009760547,0.0079151215,0.022375084],"study_design_scores_gemma":[0.007209754,0.0015676714,0.56357384,0.00030503073,0.00027586057,0.00006928671,0.0008866523,0.08110798,0.2867983,0.00018827325,0.05710918,0.00090815144],"about_ca_topic_score_codex":0.0015361299,"about_ca_topic_score_gemma":0.00006005269,"teacher_disagreement_score":0.63790035,"about_ca_system_score_codex":0.000054136803,"about_ca_system_score_gemma":0.000051257364,"threshold_uncertainty_score":0.534433},"labels":[],"label_agreement":null},{"id":"W3069741454","doi":"10.1080/19420862.2020.1802188","title":"AlbuCORE: an albumin-based molecular scaffold for multivalent biologics design","year":2020,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Zymeworks (Canada)","funders":"","keywords":"Scaffold; Human serum albumin; Fusion protein; Conjugate; Small molecule; Albumin; Computational biology; Chemistry; Protein engineering; Nanotechnology; Computer science; Combinatorial chemistry; Biochemistry; Biology; Materials science; Mathematics","score_opus":0.17030126985172084,"score_gpt":0.36887005236820813,"score_spread":0.1985687825164873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3069741454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86996406,0.0012473174,0.07370847,0.050515745,0.00015773613,0.0025717772,0.00013488602,0.00022853112,0.001471448],"genre_scores_gemma":[0.97569305,0.000021565711,0.016063081,0.0071394187,0.00023998262,0.00007669873,0.00015434786,0.000027588201,0.0005842953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988662,0.00006851279,0.0001754228,0.00032114284,0.00024425745,0.00032448542],"domain_scores_gemma":[0.9991538,0.00015520067,0.000034704513,0.00018029241,0.0001200808,0.00035589916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017687198,0.00015125943,0.0002380161,0.000043628865,0.000076302065,0.000016290183,0.0001451692,0.00008702406,0.00017786506],"category_scores_gemma":[0.00020084211,0.000110581896,0.00014029582,0.00012737719,0.000082522805,0.000025345005,0.00003028982,0.000117992255,0.00008692856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045654266,0.0004231465,0.0059741777,0.00049398676,0.00011683313,0.00028872408,0.00018255929,0.00044701237,0.96002126,0.0015955615,0.009505747,0.016385585],"study_design_scores_gemma":[0.0039218687,0.006055874,0.005059375,0.000083501334,0.00009714431,0.000018003282,0.00009836326,0.0853931,0.8006173,0.0005163091,0.09772654,0.00041262983],"about_ca_topic_score_codex":0.000029970663,"about_ca_topic_score_gemma":0.0000012747505,"teacher_disagreement_score":0.15940395,"about_ca_system_score_codex":0.000023701266,"about_ca_system_score_gemma":0.0000982032,"threshold_uncertainty_score":0.4509399},"labels":[],"label_agreement":null},{"id":"W3095061474","doi":"10.1080/19420862.2020.1836718","title":"Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants","year":2020,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Somatic hypermutation; Affinity maturation; Antibody; Biology; Complementarity determining region; Monoclonal antibody; clone (Java method); Epitope; Somatic cell; Molecular biology; Germline mutation; Mutation; Antibody Repertoire; Genetics; B cell; DNA; Gene","score_opus":0.020141683343803604,"score_gpt":0.25667511481589744,"score_spread":0.23653343147209382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095061474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997244,0.00022155156,0.00022620884,0.0014335868,0.0000620122,0.00029856735,0.00033966464,0.000014476299,0.00015991948],"genre_scores_gemma":[0.99800974,0.0001331906,0.0011050598,0.00008801569,0.000020759791,0.0000041972703,0.0005853468,0.000010639621,0.00004302964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987586,0.00007413897,0.00039495146,0.00020847078,0.00043775514,0.00012606311],"domain_scores_gemma":[0.99930125,0.000116034666,0.00020016191,0.00010130637,0.0001736897,0.000107534375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001185031,0.00012068651,0.0003453415,0.00007395519,0.00005005605,0.00001251307,0.00006489592,0.00008206949,0.00019292785],"category_scores_gemma":[0.00018063294,0.0001025265,0.000054429445,0.00012879937,0.00006944105,0.00015246913,0.00007064007,0.00012978567,0.000013322714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014862585,0.0008872258,0.67191565,0.00097216014,0.0002809127,0.000023772765,0.0013401365,0.000011741012,0.31654286,0.00026270238,0.0012784768,0.004998079],"study_design_scores_gemma":[0.0013915502,0.0005275471,0.96568984,0.00013621408,0.0000633656,0.0000075385847,0.00008050198,0.0058671404,0.025566893,0.0005279528,0.000039223112,0.00010223941],"about_ca_topic_score_codex":0.0002571824,"about_ca_topic_score_gemma":0.000004491938,"teacher_disagreement_score":0.2937742,"about_ca_system_score_codex":0.000017304666,"about_ca_system_score_gemma":0.00003333501,"threshold_uncertainty_score":0.41809094},"labels":[],"label_agreement":null},{"id":"W3102523565","doi":"10.1080/19420862.2020.1844928","title":"Impact of Fc N-linked glycans on in vivo clearance of an immunoglobulin G1 antibody produced by NS0 cell line","year":2020,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"AstraZeneca","keywords":"Glycan; Immunogenicity; Monoclonal antibody; Antibody; Glycosylation; In vivo; Chemistry; Fragment crystallizable region; Immunoglobulin G; Biochemistry; Immune system; Molecular biology; Biology; Immunology; Receptor; Glycoprotein","score_opus":0.02843821252073137,"score_gpt":0.35665179640557665,"score_spread":0.3282135838848453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102523565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948748,0.00057265186,0.000005949709,0.0024755234,0.00003407673,0.00039888924,0.00023648415,0.00001958562,0.0013820495],"genre_scores_gemma":[0.9983989,0.00026567068,0.00013131309,0.0002303002,0.00013004687,0.000004569852,0.000101412945,0.00002424505,0.0007135353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844253,0.00007679287,0.00042855492,0.00031789258,0.0004280574,0.00030617154],"domain_scores_gemma":[0.99920356,0.000054471024,0.00011474491,0.00030449676,0.00012770938,0.00019502713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018374367,0.00017587632,0.000502168,0.00009157113,0.000024356066,0.00000609186,0.0001992933,0.00008779508,0.0004639855],"category_scores_gemma":[0.00010321883,0.00013347159,0.00015383365,0.00039581503,0.00010669238,0.00005459429,0.000056941877,0.00032783975,0.00004726795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009163903,0.00084189896,0.020197429,0.0003809974,0.000048338326,0.00005347985,0.00041660585,0.00009198052,0.9660622,0.000027466842,0.0013613851,0.001354298],"study_design_scores_gemma":[0.0047232006,0.013769958,0.24557862,0.00033380135,0.000032448035,0.000010569151,0.00009795714,0.0038187604,0.72724783,0.000020100555,0.004091693,0.00027505908],"about_ca_topic_score_codex":0.0012594588,"about_ca_topic_score_gemma":0.000013565656,"teacher_disagreement_score":0.23881438,"about_ca_system_score_codex":0.000039303948,"about_ca_system_score_gemma":0.00013917065,"threshold_uncertainty_score":0.54428136},"labels":[],"label_agreement":null},{"id":"W3176850572","doi":"10.1080/19420862.2021.1933690","title":"A T cell redirection platform for co-targeting dual antigens on solid tumors","year":2021,"lang":"en","type":"article","venue":"mAbs","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Terry Fox Research Institute; Genome Canada","keywords":"Antigen; Cancer research; Cytotoxic T cell; Cytotoxicity; Antibody; Chemistry; Biology; Computational biology; In vitro; Immunology; Biochemistry","score_opus":0.04228322408717676,"score_gpt":0.34601758597425425,"score_spread":0.3037343618870775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176850572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604362,0.00019423042,0.00011180589,0.0007631881,0.00032113484,0.00044988104,0.000018944418,0.00008868463,0.03761589],"genre_scores_gemma":[0.9535718,0.00008039973,0.0005529087,0.0003909273,0.00083093945,0.00004086806,0.00018470867,0.000046304627,0.04430117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889416,0.000019415505,0.00018913322,0.00026009144,0.0003092194,0.00032798055],"domain_scores_gemma":[0.99936604,0.00012499378,0.00004153291,0.00020973236,0.00014834703,0.00010937415],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033582485,0.00010368929,0.00021238711,0.00008842388,0.00012480214,0.000026282049,0.000035586683,0.0000739189,0.001979606],"category_scores_gemma":[0.00016691038,0.0000973559,0.000117808464,0.00014681695,0.00002713766,0.000035043584,0.00002214159,0.00021191474,0.00011116452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007674539,0.00019814441,0.0009366861,0.00017031927,0.000042534866,0.00022041626,0.0004596083,0.000016842729,0.9495876,0.00005947643,0.036205593,0.011335365],"study_design_scores_gemma":[0.0017894504,0.0005477576,0.0012930605,0.00007614517,0.000018729334,0.00007377626,0.0005604601,0.0010637853,0.8513085,0.00009115982,0.14306395,0.00011317271],"about_ca_topic_score_codex":0.000019094647,"about_ca_topic_score_gemma":0.000007692595,"teacher_disagreement_score":0.10685836,"about_ca_system_score_codex":0.00012190269,"about_ca_system_score_gemma":0.00013953605,"threshold_uncertainty_score":0.9989327},"labels":[],"label_agreement":null},{"id":"W3212762770","doi":"10.1080/19420862.2021.1982447","title":"Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics","year":2021,"lang":"en","type":"review","venue":"mAbs","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Wilhelm Sander-Stiftung","keywords":"Oncolytic virus; Antibody; Immune system; Virus; Virology; Biology; Bispecific antibody; Immunotherapy; Cancer research; Computational biology; Immunology; Monoclonal antibody","score_opus":0.07056780666259906,"score_gpt":0.392729113254955,"score_spread":0.322161306592356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212762770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01186705,0.98425347,0.0019319238,0.00000992906,0.00023859723,0.0012538667,0.00040874898,0.000025284695,0.000011147369],"genre_scores_gemma":[0.00047154172,0.9956553,0.0017300872,0.00018440437,0.00036816514,0.00014473742,0.0011358511,0.00020400979,0.000105909465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759835,0.00019141157,0.0006373179,0.00071938994,0.00032217382,0.000531343],"domain_scores_gemma":[0.9982053,0.00013652814,0.00029689894,0.0009878577,0.00024979824,0.00012361901],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030850008,0.0005868098,0.0012643208,0.00025192025,0.00008297945,0.00004833997,0.00063929067,0.00056657277,0.000084460975],"category_scores_gemma":[0.000056144763,0.0005426633,0.0009853835,0.00033088995,0.00011761728,0.0000035325672,0.00014529681,0.00023069822,0.000014403702],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051876146,0.00031983457,0.000038268212,0.0074347053,0.001451005,0.000024278486,0.000017397651,0.00033096637,0.33678713,0.000009383703,0.00020732351,0.65286094],"study_design_scores_gemma":[0.0010409277,0.002012881,0.0000058543446,0.0017470845,0.0003313584,0.000009365793,0.000009966317,0.00020044862,0.048777238,0.000001912311,0.9452488,0.0006141634],"about_ca_topic_score_codex":0.000014699497,"about_ca_topic_score_gemma":0.000013195508,"teacher_disagreement_score":0.9450415,"about_ca_system_score_codex":0.000066309316,"about_ca_system_score_gemma":0.0009782957,"threshold_uncertainty_score":0.9997025},"labels":[],"label_agreement":null},{"id":"W3215962778","doi":"10.1080/19420862.2021.1997072","title":"Hydrogen-deuterium exchange mass spectrometry reveals three unique binding responses of mAbs directed to the catalytic domain of hCAIX","year":2021,"lang":"en","type":"article","venue":"mAbs","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; National Research Council Canada","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Hydrogen–deuterium exchange; Isothermal titration calorimetry; Monoclonal antibody; Enzyme; Biophysics; Conjugate; Biochemistry; Extracellular; Epitope; Antibody; Mass spectrometry; Chromatography; Biology","score_opus":0.013581175493916908,"score_gpt":0.24501783172713013,"score_spread":0.23143665623321322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215962778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939241,0.0006100862,0.002547115,0.0010516767,0.00015150277,0.00016258523,0.0001076306,0.000015789212,0.0014295296],"genre_scores_gemma":[0.99454,0.00011175341,0.001527478,0.000333732,0.00013878272,0.000019773981,0.00019225362,0.000018181978,0.0031180738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910927,0.00012629907,0.00023561678,0.00023273952,0.00013758431,0.00015850604],"domain_scores_gemma":[0.9992621,0.000027958018,0.00010251838,0.0004225387,0.00013540922,0.0000494917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003276782,0.00010650974,0.00015549362,0.00008816887,0.000049681657,0.000010010836,0.00011889682,0.00010099787,0.0001646471],"category_scores_gemma":[0.00017525286,0.00008851149,0.00009326341,0.00032510475,0.000044712728,0.0000037667937,0.00010533022,0.00006467453,0.000015825131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013582714,0.000030155148,0.0007760157,0.000042956148,0.000035869176,0.0000058118385,0.000048472066,0.0000041527765,0.99404883,0.00016746312,0.0045994394,0.00010500296],"study_design_scores_gemma":[0.00024707644,0.00018331969,0.0033029884,0.000044907654,0.000015124173,0.000022514723,0.000106667234,0.0000050062754,0.98060775,0.0001880709,0.015175532,0.00010104471],"about_ca_topic_score_codex":0.000015796028,"about_ca_topic_score_gemma":0.00007134328,"teacher_disagreement_score":0.013441086,"about_ca_system_score_codex":0.000022180964,"about_ca_system_score_gemma":0.000053315744,"threshold_uncertainty_score":0.36093938},"labels":[],"label_agreement":null},{"id":"W3216054793","doi":"10.1080/19420862.2021.2003281","title":"Agonistic nanobodies and antibodies to human VISTA","year":2021,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Monoclonal antibody; Epitope; Immune system; Antibody; Molecular biology; Splenocyte; Chemistry; Peripheral blood mononuclear cell; Biology; Immunology; In vitro; Biochemistry","score_opus":0.03276743611031343,"score_gpt":0.35278350856612495,"score_spread":0.32001607245581154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216054793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96514773,0.0016961289,0.000024399711,0.009763682,0.00007452219,0.000119383585,0.000020971445,0.00003710563,0.02311607],"genre_scores_gemma":[0.9394423,0.0002271167,0.0007594233,0.0012665627,0.00017981544,0.000007952812,0.000043420052,0.000013637604,0.058059767],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990929,0.00002551065,0.00014170351,0.00024502352,0.00023866068,0.00025620972],"domain_scores_gemma":[0.9994042,0.000055048786,0.000014327619,0.0001805986,0.00014456222,0.0002012583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008303786,0.00011046187,0.00022915586,0.000068066896,0.00020771341,0.000050430153,0.000047993883,0.000037782018,0.0004438627],"category_scores_gemma":[0.0001233636,0.00008920346,0.000050784707,0.00012098146,0.00010949676,0.000024608555,0.00017551472,0.0001185933,0.00017381807],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048124406,0.00036856296,0.19881745,0.00138979,0.00031126925,0.003305909,0.0016310285,0.0000016762508,0.67160684,0.044246707,0.054394808,0.023444695],"study_design_scores_gemma":[0.00087503984,0.0004819427,0.489176,0.00028996644,0.00006906619,0.00049116096,0.0004927344,0.000039155224,0.04206372,0.0019300807,0.46377754,0.00031358554],"about_ca_topic_score_codex":0.00012473085,"about_ca_topic_score_gemma":0.00008717051,"teacher_disagreement_score":0.6295431,"about_ca_system_score_codex":0.000017699751,"about_ca_system_score_gemma":0.00005222547,"threshold_uncertainty_score":0.48599854},"labels":[],"label_agreement":null},{"id":"W3217779163","doi":"10.1080/19420862.2021.1999194","title":"Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX","year":2021,"lang":"en","type":"article","venue":"mAbs","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; National Research Council Canada","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute; Cancer Research Institute","keywords":"Monoclonal antibody; Extracellular; Antibody; Carbonic anhydrase; Cancer cell; Enzyme; Tumor microenvironment; Cancer; Biochemistry; Biology; Chemistry; Immunology","score_opus":0.00858304745555132,"score_gpt":0.23032794380991511,"score_spread":0.22174489635436379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217779163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773645,0.00017597346,0.0006073207,0.000092265196,0.00006732547,0.000034300818,0.000014161292,0.000006211468,0.0012659616],"genre_scores_gemma":[0.9977111,0.00024398991,0.000095713716,0.00018018331,0.000098380544,0.0000022848385,0.0012131335,0.000005984022,0.00044923415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996467,0.000021354268,0.000103106795,0.0001273978,0.00004546236,0.000055984452],"domain_scores_gemma":[0.9997699,0.0000015571983,0.000048283244,0.00008841781,0.00007317203,0.000018622643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037625192,0.00005086324,0.000057156187,0.000019900492,0.000044249664,0.000009996984,0.000014984993,0.000057395147,0.000024089331],"category_scores_gemma":[0.000013135091,0.00005431698,0.000023691386,0.0000383141,0.000025329717,0.0000045773545,0.0000256715,0.000025301151,0.0000011937624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008976902,0.000018336852,0.0072896853,0.00001060387,0.000008207094,6.5388895e-7,0.000020860534,0.0000030735112,0.9919934,0.00017334553,0.00011682618,0.00035602838],"study_design_scores_gemma":[0.00023719728,0.000057057783,0.0631804,0.000014611643,0.0000052311943,0.000003951922,0.000027983597,0.00015793004,0.9333166,0.000036831912,0.0028943263,0.00006785833],"about_ca_topic_score_codex":0.0000034441662,"about_ca_topic_score_gemma":0.000011944918,"teacher_disagreement_score":0.058676787,"about_ca_system_score_codex":0.0000039128995,"about_ca_system_score_gemma":0.000016580992,"threshold_uncertainty_score":0.22149822},"labels":[],"label_agreement":null},{"id":"W4232846302","doi":"10.4161/mabs.1.5.9675","title":"Letter from the Editor","year":2009,"lang":"en","type":"letter","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Golimumab; Tocilizumab; Biosimilar; Psoriatic arthritis; Ustekinumab; Food and drug administration; Abatacept; Tofacitinib; Canakinumab; Secukinumab; Rheumatoid arthritis; Family medicine; Rituximab; Internal medicine; Etanercept; Pharmacology; Adalimumab; Immunology; Antibody; Anakinra","score_opus":0.025896550637447387,"score_gpt":0.29314766210745513,"score_spread":0.26725111147000774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232846302","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006330924,0.0010499497,0.000004446345,0.98467016,0.002942589,0.00026161005,0.00015515099,0.000041946027,0.01024106],"genre_scores_gemma":[0.00004596136,0.00008270733,0.00007923885,0.676556,0.25122917,0.000011309337,0.0008150185,0.000023889565,0.07115668],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817836,0.00007187048,0.00020090601,0.00032465314,0.0008127068,0.00041152016],"domain_scores_gemma":[0.99894506,0.00033297515,0.00005237589,0.0005238091,0.00007938794,0.00006638161],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009552869,0.000240714,0.00034314397,0.000046642814,0.00010648614,0.000050401915,0.00031962135,0.00048181022,0.00257831],"category_scores_gemma":[0.000049012408,0.00012813274,0.00023949245,0.000077044155,0.00012155499,0.000021512913,0.0000864789,0.0025378263,0.002320046],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005815213,0.000013775306,0.0002563953,0.00003753977,0.00008600026,0.00093472097,0.000029277788,2.4747218e-8,0.00008338691,0.000005193009,0.9951879,0.0033076522],"study_design_scores_gemma":[0.00024080524,0.000087231114,0.0040662745,0.00013323527,0.00006761326,0.00002785735,0.0000022116806,0.00000477741,0.00006548313,0.00029040515,0.994865,0.00014912087],"about_ca_topic_score_codex":0.0005739857,"about_ca_topic_score_gemma":0.000009653047,"teacher_disagreement_score":0.30811414,"about_ca_system_score_codex":0.000041011386,"about_ca_system_score_gemma":0.00007770263,"threshold_uncertainty_score":0.99976337},"labels":[],"label_agreement":null},{"id":"W4238740123","doi":"10.4161/mabs.2.2.11271","title":"Certolizumab Pegol","year":2010,"lang":"it","type":"review","venue":"mAbs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Certolizumab pegol; Medicine; Rheumatoid arthritis; Monoclonal antibody; Infliximab; Arthritis; Internal medicine; Adalimumab; Tumor necrosis factor alpha; Immunology; Antibody","score_opus":0.034362650401313304,"score_gpt":0.3351339835106432,"score_spread":0.3007713331093299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238740123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009764773,0.9630876,0.000014285824,0.0017282644,0.0015434717,0.0015089954,0.00010474052,0.00011175372,0.031803202],"genre_scores_gemma":[0.0017735544,0.97604,0.00011655818,0.000056107438,0.0013221486,0.00019766191,0.00030410974,0.00016180825,0.02002804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959813,0.00027419007,0.0008946624,0.0007330866,0.00096422975,0.0011525735],"domain_scores_gemma":[0.9971653,0.00027953825,0.0002714326,0.0012781287,0.00025639206,0.0007491924],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00020270553,0.00071907084,0.00229049,0.00037084954,0.0002840876,0.00018662425,0.0005968252,0.0008090948,0.020135378],"category_scores_gemma":[0.0006040867,0.00055941805,0.0008575875,0.00036988722,0.00038552476,0.000111281224,0.00022621702,0.002594444,0.022662032],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006006864,0.00016227967,0.000036039615,0.0065271496,0.0002782034,0.0016213937,0.00014481056,4.8157025e-9,0.000022707047,0.0018409835,0.008117866,0.9811885],"study_design_scores_gemma":[0.0015295779,0.00033867577,0.00003173193,0.018782744,0.00007129511,0.0044247727,0.000051854124,0.0000072372904,0.000009144558,0.00022211579,0.97404087,0.0004900077],"about_ca_topic_score_codex":0.00012777667,"about_ca_topic_score_gemma":0.00005485849,"teacher_disagreement_score":0.98069847,"about_ca_system_score_codex":0.00013117841,"about_ca_system_score_gemma":0.0010222566,"threshold_uncertainty_score":0.9997066},"labels":[],"label_agreement":null},{"id":"W4240599923","doi":"10.4161/19420862.2015.989047","title":"Recombinant renewable polyclonal antibodies","year":2014,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Ministero dello Sviluppo Economico; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; Eli Lilly Canada; GlaxoSmithKline; Académie Royale de Médecine de Belgique; Pfizer; Eli Lilly and Company","keywords":"Polyclonal antibodies; Recombinant DNA; Epitope; Antibody; Computational biology; Biology; Virology; Molecular biology; Gene; Biochemistry; Immunology","score_opus":0.019788495083520336,"score_gpt":0.2937061072653504,"score_spread":0.2739176121818301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240599923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82019997,0.00064413913,0.00019859914,0.013066751,0.00050408277,0.00021233277,0.000007937172,0.00011515129,0.16505103],"genre_scores_gemma":[0.89320517,0.00021345276,0.0015649692,0.0012037097,0.00044235738,0.000010702882,0.00004839151,0.00002355944,0.10328768],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998691,0.000048865983,0.000207273,0.0002585064,0.00038316954,0.00041117799],"domain_scores_gemma":[0.9992866,0.00009601174,0.000036737503,0.00027213249,0.00009654176,0.0002120084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002900525,0.00014503484,0.0002838724,0.00010853597,0.00015129289,0.000026019141,0.00011603011,0.00007167179,0.00087941997],"category_scores_gemma":[0.00012748639,0.00010641477,0.00012443653,0.0001466581,0.00011773065,0.000051702802,0.00009492746,0.00018697778,0.00067794765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025831147,0.001075296,0.41450793,0.00097446603,0.00037959462,0.00038188157,0.00042874375,0.00002459633,0.11795658,0.047986798,0.31059107,0.10310993],"study_design_scores_gemma":[0.0010633079,0.0005780333,0.122586206,0.0001298703,0.00003067757,0.00022158492,0.000035105382,0.00080354814,0.011184426,0.0035225204,0.85962754,0.0002171525],"about_ca_topic_score_codex":0.0007051777,"about_ca_topic_score_gemma":0.00004443596,"teacher_disagreement_score":0.5490365,"about_ca_system_score_codex":0.000027689866,"about_ca_system_score_gemma":0.000056983066,"threshold_uncertainty_score":0.9629032},"labels":[],"label_agreement":null},{"id":"W4240846338","doi":"10.4161/mabs.26545","title":"Antibody Engineering and Therapeutics Conference","year":2013,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Burnaby Hospital; Simon Fraser University","funders":"","keywords":"Antibody; Epitope; Bispecific antibody; Thursday; Computational biology; Antibody Repertoire; Complementarity determining region; Computer science; Medicine; Immunology; Biology; Monoclonal antibody","score_opus":0.031349997729425615,"score_gpt":0.3147012490431212,"score_spread":0.2833512513136956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240846338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904002,0.00051332626,0.00022094332,0.003685526,0.000036763966,0.00013905758,0.0000017784348,0.000028520519,0.0049738777],"genre_scores_gemma":[0.9946482,0.00031524902,0.000669653,0.00043798742,0.000070332004,0.000006627517,0.000013231435,0.0000072568982,0.0038314527],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995697,0.0000053392787,0.00006830371,0.00009035403,0.000116794436,0.00014946522],"domain_scores_gemma":[0.99973446,0.00003018311,0.00000802086,0.00008024969,0.00006081453,0.0000862719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035564084,0.00006185538,0.00009687184,0.000034037042,0.000027137663,0.000025368035,0.00003313708,0.00003056977,0.0005317563],"category_scores_gemma":[0.00000966591,0.00004433127,0.000019120956,0.00004400651,0.000036940328,0.000036507197,0.000035095196,0.00010563392,0.00018134747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053037013,0.000068061214,0.08496566,0.00029165813,0.00010070535,0.000042662323,0.0003539841,0.0000019137924,0.86344403,0.006104475,0.00060286897,0.04397092],"study_design_scores_gemma":[0.0007926071,0.00031380705,0.83160555,0.00014116777,0.00003114724,0.0001823607,0.00011714874,0.021608531,0.008657611,0.0006090147,0.13571823,0.00022284812],"about_ca_topic_score_codex":0.00010403504,"about_ca_topic_score_gemma":9.670727e-7,"teacher_disagreement_score":0.85478646,"about_ca_system_score_codex":0.000005215009,"about_ca_system_score_gemma":0.000015107679,"threshold_uncertainty_score":0.5822359},"labels":[],"label_agreement":null},{"id":"W4240893127","doi":"10.4161/mabs.1.5.9286","title":"Golimumab","year":2009,"lang":"pl","type":"review","venue":"mAbs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.04014394446193942,"score_gpt":0.3484682045420788,"score_spread":0.30832426008013936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240893127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005394127,0.9674263,0.000014343809,0.00084525195,0.00052095024,0.0011699029,0.00005900362,0.00010399222,0.029806301],"genre_scores_gemma":[0.0004960376,0.9816381,0.00009329449,0.00030341384,0.00087751955,0.00006586696,0.00026663856,0.00008857694,0.01617055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963962,0.00030374303,0.00081975234,0.00061731524,0.00083727686,0.001025739],"domain_scores_gemma":[0.99791753,0.00019204464,0.00021539866,0.00093321316,0.00016721203,0.00057458755],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00053305033,0.0006208598,0.002237248,0.00033540686,0.00019715549,0.00014190163,0.00043866728,0.00043835194,0.006889408],"category_scores_gemma":[0.00033916908,0.0004889119,0.0007674747,0.0004210719,0.0001979662,0.00009307481,0.00010664539,0.001116714,0.018006237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046341112,0.00017362942,0.00001283055,0.004573625,0.00030039306,0.00041456497,0.00009547748,4.2349892e-8,0.0000029541218,0.0013763034,0.020785963,0.97221786],"study_design_scores_gemma":[0.0013592368,0.00063749467,0.000088650355,0.03532139,0.00006299412,0.00039756062,0.000033381035,0.0000055028495,0.0000029569808,0.0003908324,0.9612945,0.0004055567],"about_ca_topic_score_codex":0.000054983582,"about_ca_topic_score_gemma":0.000014911784,"teacher_disagreement_score":0.9718123,"about_ca_system_score_codex":0.00019676187,"about_ca_system_score_gemma":0.0007236909,"threshold_uncertainty_score":0.9997563},"labels":[],"label_agreement":null},{"id":"W4251934156","doi":"10.1080/19420862.2015.1089707","title":"Antibody Engineering &amp; Therapeutics 2015: The Antibody Society's annual meeting December 7–10, 2015, San Diego, CA","year":2015,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada); Burnaby Hospital; Simon Fraser University","funders":"National Cancer Institute","keywords":"Antibody; Medicine; Session (web analytics); Immunotherapy; Computational biology; Immunology; Immune system; Biology; Computer science","score_opus":0.043502625963350874,"score_gpt":0.3676728895309278,"score_spread":0.32417026356757694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251934156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9410513,0.013230584,0.001388051,0.017620455,0.0009984842,0.0009380318,0.00017959754,0.00029348212,0.02430002],"genre_scores_gemma":[0.91434956,0.0010648353,0.004428862,0.003066951,0.0027836508,0.000038785438,0.0010878085,0.00017655305,0.07300301],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974889,0.000085755906,0.00037309513,0.000374015,0.00092062465,0.0007575753],"domain_scores_gemma":[0.9983405,0.00024272465,0.00008439572,0.000512386,0.00044860362,0.0003714238],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000901976,0.00032711058,0.00040206555,0.00007696645,0.00023227517,0.000076505734,0.0003207081,0.00017061485,0.0009111499],"category_scores_gemma":[0.0001500388,0.00021009061,0.00027199351,0.00033553477,0.00018689533,0.00013112991,0.00026156558,0.00058343646,0.0009064595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008093444,0.00041655984,0.05219743,0.00036328897,0.0009964498,0.0001476469,0.006380417,0.00041566754,0.118774205,0.00046988056,0.81599474,0.0030343698],"study_design_scores_gemma":[0.0010361875,0.00022190779,0.012672832,0.00013867792,0.00011498509,0.00016262732,0.0008176259,0.0046930243,0.00094477466,0.00006968255,0.9787969,0.000330779],"about_ca_topic_score_codex":0.00042269457,"about_ca_topic_score_gemma":0.000114998664,"teacher_disagreement_score":0.16280216,"about_ca_system_score_codex":0.000086812935,"about_ca_system_score_gemma":0.00020631163,"threshold_uncertainty_score":0.99987143},"labels":[],"label_agreement":null},{"id":"W4255303081","doi":"10.4161/mabs.1.3.8593","title":"Ustekinumab","year":2009,"lang":"sw","type":"review","venue":"mAbs","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ustekinumab; Medicine; Psoriatic arthritis; Psoriasis; Food and drug administration; Dermatology; Biosimilar; Plaque psoriasis; Clinical trial; Disease; Internal medicine; Pharmacology; Adalimumab","score_opus":0.03684663513344908,"score_gpt":0.28531856196487343,"score_spread":0.24847192683142436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255303081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039534504,0.97996897,0.000007025983,0.00013487804,0.0033929073,0.0008061171,0.00028590948,0.000119965676,0.014888859],"genre_scores_gemma":[0.00057699636,0.9252562,0.000038410337,0.0001749306,0.00045297886,0.00008249633,0.0016548147,0.000064452346,0.07169872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656266,0.00078982726,0.000844913,0.0008759629,0.00006850867,0.0008581076],"domain_scores_gemma":[0.9981634,0.00025570826,0.00047756222,0.0009636188,0.00007126511,0.000068420704],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025884583,0.0010013826,0.0024129928,0.000275217,0.0003487563,0.000045676974,0.00062435266,0.0018326064,0.0061530275],"category_scores_gemma":[0.000051357998,0.0007730954,0.0012020333,0.00030189217,0.00015247948,0.00006609497,0.00012573846,0.00062282744,0.027711099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060805083,0.0003721337,0.000019391557,0.001273094,0.0013127762,0.00011780836,0.00006890568,6.67967e-8,0.000047421436,0.0005909288,0.013953084,0.9821836],"study_design_scores_gemma":[0.0015933973,0.00036169548,0.00019496736,0.0031339624,0.0035474573,0.0004056498,0.000022622751,8.2438895e-8,0.000111137786,0.00010063027,0.9898117,0.00071666704],"about_ca_topic_score_codex":0.000031697287,"about_ca_topic_score_gemma":0.000023586525,"teacher_disagreement_score":0.9814669,"about_ca_system_score_codex":0.000200573,"about_ca_system_score_gemma":0.00021321417,"threshold_uncertainty_score":0.999472},"labels":[],"label_agreement":null},{"id":"W4310573307","doi":"10.1080/19420862.2022.2149057","title":"A glyco-engineering approach for site-specific conjugation to Fab glycans","year":2022,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"National Research Council Canada","keywords":"Chemistry; Glycan; Epitope; Antibody-drug conjugate; Glycosylation; Monoclonal antibody; Linker; Combinatorial chemistry; Antibody; Drug; Glycoprotein; Biochemistry; Pharmacology; Biology; Computer science","score_opus":0.03186125103665228,"score_gpt":0.2829580887410076,"score_spread":0.2510968377043553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310573307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95916,0.0005968545,0.022647498,0.0068737827,0.0002980041,0.0016992593,0.00027466504,0.00012881367,0.008321153],"genre_scores_gemma":[0.97173756,0.000015350844,0.010733879,0.0008352564,0.00038751328,0.0005599817,0.0004731614,0.000032757114,0.015224533],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990267,0.000015093107,0.00014065878,0.00022093418,0.0003321958,0.0002643865],"domain_scores_gemma":[0.99956656,0.00006301643,0.000017401042,0.00015252476,0.000059501315,0.00014098213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018313328,0.00009336834,0.00015886336,0.00012213002,0.00017053426,0.00001717837,0.00009039938,0.000023119655,0.00048267358],"category_scores_gemma":[0.000033776745,0.000086453045,0.000083589235,0.00021566899,0.000013497033,0.00001901489,0.000103040904,0.0001729255,0.00004955465],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012661102,0.0013888632,0.013298441,0.0018555007,0.00035377336,0.00023163983,0.0055072047,0.026450312,0.4957888,0.05114808,0.34132585,0.049990423],"study_design_scores_gemma":[0.0009837097,0.0006312114,0.0033891883,0.000011463821,0.000013518209,0.00006365234,0.00024877573,0.01674939,0.0016585747,0.000045252906,0.9760556,0.0001496161],"about_ca_topic_score_codex":0.000053388943,"about_ca_topic_score_gemma":0.0000018260561,"teacher_disagreement_score":0.6347298,"about_ca_system_score_codex":0.000102601865,"about_ca_system_score_gemma":0.000034282017,"threshold_uncertainty_score":0.52849376},"labels":[],"label_agreement":null},{"id":"W4317717717","doi":"10.1080/19420862.2023.2168470","title":"Selection of target-binding proteins from the information of weakly enriched phage display libraries by deep sequencing and machine learning","year":2023,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Research Institute for Information Technology, Kyushu University; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Institute of Genetics; University of Tokyo","keywords":"Biopanning; Deep sequencing; Sequence space; Computational biology; Phage display; Biology; Sequence (biology); DNA sequencing; Selection (genetic algorithm); Deep learning; Sequence analysis; Artificial intelligence; Genetics; Peptide library; Computer science; Peptide sequence; Gene; Genome","score_opus":0.01883145851645423,"score_gpt":0.255192265777876,"score_spread":0.23636080726142178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317717717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973478,0.00039575476,0.0005426952,0.0008558786,0.000025071375,0.00023943926,0.000047869085,0.000035284007,0.0005102558],"genre_scores_gemma":[0.9978682,0.00014570521,0.00054502743,0.000042988784,0.000042175136,0.000011674231,0.0003875317,0.0000071619324,0.00094956724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926865,0.00005105027,0.000209556,0.00007761114,0.00025522572,0.00013788657],"domain_scores_gemma":[0.9995672,0.00018364078,0.00009835277,0.000059662405,0.000051098825,0.000040005034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023276915,0.000073738025,0.00015418592,0.00007777359,0.00012724899,0.000020373496,0.000049739432,0.0000431476,0.00010925019],"category_scores_gemma":[0.00019802553,0.000047623063,0.000033181765,0.0003014247,0.00007136587,0.00022708571,0.00006892415,0.00020178036,0.000014565315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041820027,0.000022175636,0.22188137,0.00040950745,0.00011845396,0.0000039593438,0.0050148047,0.00006683798,0.76016694,0.00086523814,0.0008098685,0.010222625],"study_design_scores_gemma":[0.0020068449,0.0009539185,0.28996697,0.00039181928,0.00010249986,0.000030436942,0.0041110315,0.13403882,0.53955275,0.001156939,0.027386993,0.0003009932],"about_ca_topic_score_codex":0.0009748404,"about_ca_topic_score_gemma":0.000017496308,"teacher_disagreement_score":0.22061422,"about_ca_system_score_codex":0.000018691602,"about_ca_system_score_gemma":0.000041696683,"threshold_uncertainty_score":0.19420122},"labels":[],"label_agreement":null},{"id":"W4378193861","doi":"10.1080/19420862.2023.2212415","title":"Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2","year":2023,"lang":"en","type":"article","venue":"mAbs","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Zymeworks (Canada)","funders":"","keywords":"Decoy; Avidity; Potency; Neutralization; Virology; Virus; In vivo; Antibody; Chemistry; Biology; Immunology; In vitro; Biochemistry; Receptor; Genetics","score_opus":0.050627028557743536,"score_gpt":0.35202632242658,"score_spread":0.30139929386883646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378193861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374115,0.0007632089,0.00046069143,0.0019286672,0.0004109035,0.0006541198,0.000015317211,0.00014856567,0.0018773682],"genre_scores_gemma":[0.98671865,0.00009950505,0.00006305755,0.0125683835,0.00026539824,0.000077479606,0.000006789847,0.000041261254,0.00015946565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978754,0.00013634138,0.00036747422,0.00036848223,0.0007310648,0.00052124745],"domain_scores_gemma":[0.99868083,0.00042856872,0.00010020913,0.0006000111,0.00015890991,0.000031475203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054037786,0.00020994067,0.00034121875,0.00021696667,0.00015794653,0.00003992885,0.00038580515,0.00012198976,0.000025247113],"category_scores_gemma":[0.00028986248,0.00013793011,0.00021422855,0.00068283227,0.00022296254,0.00006859919,0.00017430984,0.0002530277,0.00059419364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026120193,0.00019317342,0.002124661,0.00017099155,0.00018539856,0.00032891444,0.00043774888,0.000007289924,0.9782311,0.00015311202,0.0017510585,0.016155383],"study_design_scores_gemma":[0.002000086,0.00033842784,0.032070987,0.00022180914,0.00014820001,0.000050543968,0.00041920916,0.004326852,0.9266074,0.0006758052,0.03291729,0.00022342404],"about_ca_topic_score_codex":0.00019623448,"about_ca_topic_score_gemma":0.000053007603,"teacher_disagreement_score":0.051623702,"about_ca_system_score_codex":0.00006312557,"about_ca_system_score_gemma":0.00021392576,"threshold_uncertainty_score":0.7637356},"labels":[],"label_agreement":null},{"id":"W4380153196","doi":"10.1080/19420862.2023.2218951","title":"Affinity-controlled capture and release of engineered monoclonal antibodies by macroporous dextran hydrogels using coiled-coil interactions","year":2023,"lang":"en","type":"article","venue":"mAbs","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Polytechnique Montréal; National Research Council Canada","funders":"Fonds de recherche du Québec – Nature et technologies; European Research Council; Natural Sciences and Engineering Research Council of Canada; Xunta de Galicia; Agencia Estatal de Investigación; Canada First Research Excellence Fund; Canada Research Chairs; Polytechnique Montréal","keywords":"Monoclonal antibody; Self-healing hydrogels; Chemistry; Dextran; Peptide; Antibody; Biophysics; Trastuzumab; Ligand (biochemistry); Biochemistry; Receptor; Polymer chemistry; Biology; Immunology","score_opus":0.017321460135334907,"score_gpt":0.2752813047295818,"score_spread":0.25795984459424687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380153196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964052,0.000727289,0.0012658788,0.00018666389,0.00022019498,0.00017872301,0.000075750424,0.00030441405,0.0006359114],"genre_scores_gemma":[0.99817723,0.00024101933,0.0010665111,0.000011812746,0.000054349475,0.000015674976,0.000033827644,0.000039088205,0.00036050938],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99886656,0.00004065065,0.00030246878,0.00017367727,0.00028037792,0.00033629476],"domain_scores_gemma":[0.9991931,0.0003896252,0.00003592127,0.00018110334,0.000059162692,0.00014111468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002844759,0.00015614118,0.000311011,0.00021629591,0.0000745257,0.00003549406,0.00013576429,0.00009528662,0.00010949081],"category_scores_gemma":[0.00037292953,0.0001497443,0.00007279007,0.00036089608,0.00010611367,0.00008299382,0.00007311433,0.00034051473,0.000031086234],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020102313,0.00009671271,0.0023251856,0.00072603155,0.00045509794,0.0001371125,0.0009746839,0.018527865,0.95403516,0.00019037606,0.010135142,0.012195581],"study_design_scores_gemma":[0.0044291643,0.0000580788,0.003076706,0.0002998456,0.000096850745,0.000072871044,0.0003827011,0.91086334,0.07058768,0.0003572699,0.0092229685,0.0005524956],"about_ca_topic_score_codex":0.00012828568,"about_ca_topic_score_gemma":0.000019432504,"teacher_disagreement_score":0.8923355,"about_ca_system_score_codex":0.00004458851,"about_ca_system_score_gemma":0.00002490846,"threshold_uncertainty_score":0.6106396},"labels":[],"label_agreement":null},{"id":"W4385294463","doi":"10.1080/19420862.2023.2239405","title":"Bivalent non-human gal-α1-3-gal glycan epitopes in the Fc region of a monoclonal antibody model can be recognized by anti-Gal-α1-3-Gal IgE antibodies","year":2023,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Health Canada","funders":"Government of Canada","keywords":"Bivalent (engine); Monoclonal antibody; Epitope; Antibody; Glycan; Immunoglobulin E; Chemistry; Molecular biology; Biology; Immunology; Glycoprotein","score_opus":0.06072787208077493,"score_gpt":0.37384557808385677,"score_spread":0.31311770600308186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385294463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745578,0.00070959446,0.000054466997,0.018482467,0.00023911371,0.0011460946,0.0005129634,0.00012379956,0.0041736737],"genre_scores_gemma":[0.98731774,0.0024348402,0.00024324919,0.00084477785,0.00041521128,0.00008804417,0.0012310348,0.00008890419,0.007336211],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99484026,0.00031236408,0.001067954,0.00090057094,0.0016064811,0.0012723611],"domain_scores_gemma":[0.9979029,0.00032740599,0.00028580127,0.0008227971,0.00032452328,0.00033652413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012003054,0.00060897134,0.0011757775,0.00069855736,0.0004353924,0.000093906296,0.0007673602,0.00030150532,0.00016809971],"category_scores_gemma":[0.00019689227,0.00043868084,0.00045685424,0.0011569082,0.00062205567,0.00019077993,0.0003921249,0.00095986435,0.00009253439],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005000359,0.0024301023,0.2700881,0.0023771033,0.0008494443,0.0029041963,0.008735954,0.00038493855,0.47115532,0.0021987841,0.22525582,0.008619879],"study_design_scores_gemma":[0.016974479,0.004816391,0.78872085,0.0029499282,0.0006311492,0.00096597517,0.004731843,0.067282915,0.05279287,0.0039129606,0.053325832,0.0028948395],"about_ca_topic_score_codex":0.0056788065,"about_ca_topic_score_gemma":0.00088529236,"teacher_disagreement_score":0.5186327,"about_ca_system_score_codex":0.00012571532,"about_ca_system_score_gemma":0.0003267106,"threshold_uncertainty_score":0.9998065},"labels":[],"label_agreement":null},{"id":"W4386151888","doi":"10.1080/19420862.2023.2248672","title":"Unique epitope–antibody interactions in the intrinsically disordered proteoglycan-like domain of human carbonic anhydrase IX defined by high-resolution NMR combined with yeast surface display","year":2023,"lang":"en","type":"article","venue":"mAbs","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"National Research Council Canada","keywords":"Epitope; Chemistry; Epitope mapping; Nuclear magnetic resonance spectroscopy; Carbonic anhydrase; Linear epitope; Biochemistry; Surface plasmon resonance; Biophysics; Antibody; Molecular biology; Biology; Enzyme; Stereochemistry","score_opus":0.007115238545590655,"score_gpt":0.24980120367939307,"score_spread":0.24268596513380242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386151888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702656,0.000037891077,0.00089536305,0.0010881816,0.00008347702,0.0004483139,0.000058210357,0.000028117083,0.00033389282],"genre_scores_gemma":[0.9972876,0.000037330028,0.000107950524,0.0001317238,0.000038753078,0.00006588547,0.0017947126,0.000018592185,0.000517499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902135,0.0001681639,0.00023056637,0.00024881592,0.00014029836,0.00019077602],"domain_scores_gemma":[0.9994838,0.000019125237,0.00010166249,0.0002975527,0.00006089322,0.000036951682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021950327,0.00013517597,0.0001369294,0.000057198897,0.000100289995,0.00002054333,0.0001269132,0.00007507262,0.000020111036],"category_scores_gemma":[0.000035183144,0.00010110082,0.00004754199,0.00032308648,0.00009388194,0.000009284958,0.000055882523,0.00015082043,0.000009458126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032478053,0.00024433213,0.0016824667,0.000021448946,0.000022604112,0.0000042406155,0.000108984874,0.00032167396,0.99006414,0.0015006323,0.005654158,0.00005050769],"study_design_scores_gemma":[0.018285725,0.009932115,0.14673525,0.00059528823,0.00016614964,0.00007384528,0.0036827172,0.003103755,0.74268645,0.0023305102,0.070481844,0.0019263433],"about_ca_topic_score_codex":0.00054203416,"about_ca_topic_score_gemma":0.0020813958,"teacher_disagreement_score":0.24737771,"about_ca_system_score_codex":0.000023838953,"about_ca_system_score_gemma":0.000042381056,"threshold_uncertainty_score":0.41227716},"labels":[],"label_agreement":null},{"id":"W4392516312","doi":"10.1080/19420862.2024.2323706","title":"Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge","year":2024,"lang":"en","type":"article","venue":"mAbs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Structural Genomics Consortium; Montreal Neurological Institute and Hospital","funders":"NIHR Leicester Biomedical Research Centre; Biotechnology and Biological Sciences Research Council; National Institute of General Medical Sciences; Directorate for Biological Sciences; Ontario Genomics; National Institute for Health and Care Research; Genome Canada","keywords":"Context (archaeology); Computer science; Quality (philosophy); Exploit; Data science; Biochemical engineering; Risk analysis (engineering); Business; Engineering; Computer security; Biology","score_opus":0.3319024866860573,"score_gpt":0.4848507462807238,"score_spread":0.15294825959466646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392516312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92181903,0.051148076,0.00009143469,0.02482722,0.00037521106,0.00055573374,0.00031316784,0.00012331562,0.0007468089],"genre_scores_gemma":[0.99769104,0.0012573454,0.00048324052,0.000043542612,0.000046197794,0.0000055637774,0.000011144384,0.0000075364983,0.00045441647],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982258,0.00027028506,0.00019384224,0.0010190343,0.000050256007,0.00024077714],"domain_scores_gemma":[0.9976409,0.00038577107,0.00002880783,0.0018683404,0.00005636258,0.000019808025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064195846,0.00009518011,0.000195889,0.00009713993,0.00015881279,0.000059309063,0.0004731145,0.00021009306,0.000056911947],"category_scores_gemma":[0.0016461754,0.000054147215,0.000029719464,0.00019390564,0.0017402836,0.00008986727,0.0020328527,0.0008714429,0.0000030128065],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029756303,0.0007014987,0.05994617,0.0015749072,0.00027944968,0.000029045492,0.0017201465,1.3670176e-8,0.5523998,0.051739372,0.01208528,0.31922674],"study_design_scores_gemma":[0.0018570625,0.003408552,0.3893181,0.0018848171,0.0008452047,0.0007212553,0.0073203356,0.00057011476,0.25234196,0.07220928,0.26815286,0.0013704704],"about_ca_topic_score_codex":0.0017446835,"about_ca_topic_score_gemma":0.00023357729,"teacher_disagreement_score":0.32937193,"about_ca_system_score_codex":0.000017073875,"about_ca_system_score_gemma":0.000062091625,"threshold_uncertainty_score":0.6412147},"labels":[],"label_agreement":null},{"id":"W4401914474","doi":"10.1080/19420862.2024.2394229","title":"Developability considerations for bispecific and multispecific antibodies","year":2024,"lang":"en","type":"review","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AbCellera (Canada)","funders":"","keywords":"Bispecific antibody; Computer science; Immunogenicity; Adept; Computational biology; Antibody; Biology; Monoclonal antibody; Immunology","score_opus":0.2307935514832632,"score_gpt":0.45192299809098546,"score_spread":0.22112944660772227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401914474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059547423,0.99458957,0.000017853763,0.0009735666,0.00035412362,0.0017682239,0.00055191136,0.00007686015,0.0016083171],"genre_scores_gemma":[0.000048276335,0.9845544,0.0034694772,0.000054318272,0.00047890592,0.00025737335,0.0002852712,0.00005915909,0.010792784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816924,0.00006147075,0.0005681432,0.0006155494,0.00024125156,0.00034431226],"domain_scores_gemma":[0.9983825,0.00088682404,0.000070257614,0.0003054678,0.00017601617,0.00017894182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030948693,0.00038452382,0.0014185691,0.000269038,0.00020905146,0.00012126713,0.00006965424,0.00023080596,0.0002853177],"category_scores_gemma":[0.00034940435,0.0002511978,0.00043456053,0.00019125376,0.0002731069,0.000034457036,0.00014044793,0.00045717822,0.00031931748],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040370716,0.000081623,0.00005142436,0.10141957,0.00047749098,0.00015900318,0.00010732661,1.48718025e-8,0.0000058966093,0.011544777,0.04847062,0.8376419],"study_design_scores_gemma":[0.00017889916,0.00008558672,0.00009825185,0.006099179,0.00075325446,0.0004626292,0.000020526102,0.000012576591,0.0000029117036,0.0016386966,0.9903997,0.00024778815],"about_ca_topic_score_codex":0.000019340094,"about_ca_topic_score_gemma":0.000031244872,"teacher_disagreement_score":0.9419291,"about_ca_system_score_codex":0.00008732658,"about_ca_system_score_gemma":0.00045816627,"threshold_uncertainty_score":0.99999404},"labels":[],"label_agreement":null},{"id":"W4402617448","doi":"10.1080/19420862.2024.2404064","title":"Sequence-based engineering of pH-sensitive antibodies for tumor targeting or endosomal recycling applications","year":2024,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Endosome; Antibody; Sequence (biology); Chemistry; Computational biology; Cell biology; Biochemistry; Computer science; Biology; Immunology; Receptor","score_opus":0.049116319350141394,"score_gpt":0.34952992865688065,"score_spread":0.30041360930673927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402617448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9510659,0.0036541906,0.035013296,0.004959542,0.00035712062,0.0020920425,0.00053558714,0.00035002746,0.0019722793],"genre_scores_gemma":[0.97806746,0.00006318422,0.019753592,0.00011191617,0.00043240187,0.00013692217,0.00011423686,0.00002832345,0.0012919902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907035,0.000011955214,0.00024520262,0.000222415,0.0001964897,0.0002535865],"domain_scores_gemma":[0.99907595,0.00055981753,0.000031279615,0.00010594127,0.00014740771,0.00007960366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019943838,0.00011743502,0.00023282382,0.00014642772,0.000072032184,0.000020097275,0.0000593195,0.00003651037,0.000059597478],"category_scores_gemma":[0.00019473514,0.00008622343,0.00012921843,0.00022060206,0.000065114524,0.000041243027,0.000028910472,0.00015426143,0.000020643223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008466202,0.00009326037,0.0017727464,0.0051590395,0.00020493222,0.0002620622,0.00035057744,0.00037847817,0.97007316,0.0061123236,0.0010237319,0.013723037],"study_design_scores_gemma":[0.0011358609,0.0006007461,0.002080828,0.0019542396,0.00016359394,0.00016151226,0.00042359988,0.19610894,0.62876654,0.00028783307,0.16793634,0.0003799686],"about_ca_topic_score_codex":0.000047609232,"about_ca_topic_score_gemma":0.0000031420516,"teacher_disagreement_score":0.34130666,"about_ca_system_score_codex":0.00003828782,"about_ca_system_score_gemma":0.00015964716,"threshold_uncertainty_score":0.35160896},"labels":[],"label_agreement":null},{"id":"W4404822470","doi":"10.1080/19420862.2024.2435476","title":"Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery","year":2024,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"OmniActive Health Technologies (Canada)","funders":"","keywords":"Antibody; Epitope; Immunogenicity; Heavy chain; Single-domain antibody; Immunoglobulin light chain; Biology; Transgene; Antigen; Immune system; Computational biology; Ex vivo; Genetically modified mouse; Immunology; In vivo; Cell biology; Genetics; Gene","score_opus":0.03386018991941837,"score_gpt":0.36791414652190785,"score_spread":0.3340539566024895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404822470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842464,0.004876776,0.00059365074,0.0070924237,0.00012054756,0.0011390101,0.000107258726,0.00010216412,0.0017218133],"genre_scores_gemma":[0.98788106,0.0005283072,0.00027040226,0.00032399225,0.0001968914,0.00007881623,0.00019828942,0.000058539605,0.010463708],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99818814,0.000055734166,0.0003191428,0.00047564198,0.00039555767,0.0005658002],"domain_scores_gemma":[0.99932516,0.00020505721,0.000024444322,0.00026231314,0.000065314096,0.00011770613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003262839,0.00026283224,0.0004791781,0.00027859057,0.00013922752,0.00010845767,0.00013022944,0.00008923153,0.00015520342],"category_scores_gemma":[0.000013689611,0.00017014326,0.00021917168,0.00036099434,0.0002283794,0.00015656259,0.00003233666,0.00036013537,0.000027808226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01764604,0.0019536573,0.24805056,0.0117280185,0.0019073446,0.0011120035,0.008049346,0.000024590337,0.5925345,0.09262489,0.0016208146,0.022748264],"study_design_scores_gemma":[0.020878537,0.012483355,0.65051544,0.00655461,0.0008914721,0.0010371075,0.0027056986,0.0066440855,0.039489686,0.015169437,0.24116209,0.0024685026],"about_ca_topic_score_codex":0.0002624673,"about_ca_topic_score_gemma":0.0006611804,"teacher_disagreement_score":0.5530448,"about_ca_system_score_codex":0.00006552496,"about_ca_system_score_gemma":0.00026464407,"threshold_uncertainty_score":0.69382405},"labels":[],"label_agreement":null},{"id":"W4407001865","doi":"10.1080/19420862.2025.2456467","title":"Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study","year":2025,"lang":"en","type":"article","venue":"mAbs","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"Vir Biotechnology","keywords":"Tolerability; Phase (matter); COSMIC cancer database; Intramuscular injection; Medicine; Pharmacology; Internal medicine; Chemistry; Physics; Adverse effect; Astronomy","score_opus":0.017559963454297996,"score_gpt":0.30434807449817336,"score_spread":0.28678811104387536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407001865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965388,0.00041312884,0.00027798596,0.0009431839,0.00031184548,0.001098132,0.00007978415,0.000040594696,0.00029649792],"genre_scores_gemma":[0.9991852,0.000039142902,0.000042221483,0.0002285753,0.00007199655,0.000026870202,0.00010492303,0.00000899373,0.00029209725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986167,0.00022979753,0.00046639133,0.00035022845,0.00018537111,0.00015153462],"domain_scores_gemma":[0.9986978,0.00041383287,0.0000991106,0.0006103393,0.00012508144,0.000053828648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040608624,0.0001571429,0.00041080068,0.000067140994,0.00019216658,0.000016779823,0.000068971196,0.00007812205,0.00003800795],"category_scores_gemma":[0.00057949167,0.00009960324,0.0001099578,0.00019769573,0.00015015181,0.000032111235,0.00009973821,0.00019300642,0.000004195436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13258332,0.028352229,0.29738772,0.0025026326,0.008831315,0.00025685164,0.05663867,0.0003680518,0.20456277,0.0013011778,0.016317628,0.25089765],"study_design_scores_gemma":[0.05847459,0.010764125,0.87512153,0.00081791735,0.002327544,0.00007197177,0.013483135,0.005576265,0.0237937,0.0008488767,0.008241672,0.0004786413],"about_ca_topic_score_codex":0.0003255041,"about_ca_topic_score_gemma":0.00039118325,"teacher_disagreement_score":0.5777339,"about_ca_system_score_codex":0.00019743858,"about_ca_system_score_gemma":0.00003913722,"threshold_uncertainty_score":0.40617022},"labels":[],"label_agreement":null},{"id":"W4410876964","doi":"10.1080/19420862.2025.2512217","title":"Does one model fit all mAbs? An evaluation of population pharmacokinetic models","year":2025,"lang":"en","type":"article","venue":"mAbs","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Pharmacokinetics; Population; Population pharmacokinetics; Computer science; Computational biology; Medicine; Biology; Pharmacology","score_opus":0.8192363584553051,"score_gpt":0.6473883407274934,"score_spread":0.17184801772781166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410876964","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20639296,0.00003502378,0.7874925,0.0009794916,0.00062798714,0.0010915556,0.00008792792,0.00010287102,0.003189688],"genre_scores_gemma":[0.59132373,0.0000105903255,0.40816504,0.00013336448,0.0000567075,0.000048354974,0.0000091249985,0.000013557686,0.00023956201],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9972606,0.00078662974,0.0008296518,0.0002999547,0.0006578586,0.00016531513],"domain_scores_gemma":[0.99453616,0.004395595,0.00023497731,0.0004635429,0.00030877665,0.000060961676],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0043884595,0.00013367887,0.00041245075,0.00010170976,0.00003563363,0.000018805815,0.0001914675,0.00012712943,0.00034269242],"category_scores_gemma":[0.012199234,0.000094515555,0.000082544364,0.00015993357,0.000043594446,0.00012435914,0.00006727426,0.00013327281,0.0000053853587],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026760547,0.0008802761,0.00012098699,0.0005028339,0.00018592077,5.9068657e-7,0.00022869273,0.10953493,0.0030831904,0.7743369,0.00089646195,0.109961666],"study_design_scores_gemma":[0.00061938947,0.000018861729,0.00023679706,0.000052449745,0.00030048864,5.0236512e-8,0.000005830458,0.48044157,0.0007619905,0.51749927,0.000005129597,0.000058174308],"about_ca_topic_score_codex":0.000033356908,"about_ca_topic_score_gemma":0.0000116946085,"teacher_disagreement_score":0.38493076,"about_ca_system_score_codex":0.00008179908,"about_ca_system_score_gemma":0.00004382766,"threshold_uncertainty_score":0.9961214},"labels":[],"label_agreement":null},{"id":"W4412553255","doi":"10.1080/19420862.2025.2534626","title":"AlphaBind, a domain-specific model to predict and optimize antibody–antigen binding affinity","year":2025,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alpha Technologies (Canada)","funders":"","keywords":"Antibody; Antigen; Computational biology; Chemistry; Domain (mathematical analysis); Computer science; Biology; Immunology; Mathematics","score_opus":0.03172860103541417,"score_gpt":0.34079032342059373,"score_spread":0.3090617223851796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412553255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611631,0.0009562787,0.0063694497,0.0074713174,0.0001333151,0.00052060577,0.00005652035,0.00006711314,0.023262307],"genre_scores_gemma":[0.9412022,0.0016798382,0.02855207,0.0015490141,0.00021945935,0.00004790546,0.00009011351,0.000033501106,0.026625866],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852717,0.00003674337,0.00025209135,0.0004000681,0.00035032615,0.0004335731],"domain_scores_gemma":[0.99918896,0.00011260186,0.000027627899,0.0002887428,0.00009712718,0.00028495915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030575754,0.00018597615,0.00034412206,0.0003046334,0.00021482175,0.00005551433,0.0001482077,0.00009922579,0.00016613171],"category_scores_gemma":[0.00003430344,0.00015112448,0.00009275739,0.0003743397,0.00011421553,0.00005914374,0.00027189756,0.00026927044,0.00012746452],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008627267,0.0010932687,0.23324896,0.0014036322,0.0008855533,0.0008106423,0.0022516365,0.0010540014,0.47647575,0.07126009,0.15726602,0.04562318],"study_design_scores_gemma":[0.0074245064,0.00095260044,0.21761502,0.0013731319,0.000119707074,0.00018351158,0.0008862164,0.01543654,0.019817999,0.004435509,0.7308162,0.0009390557],"about_ca_topic_score_codex":0.000045494013,"about_ca_topic_score_gemma":0.00000752744,"teacher_disagreement_score":0.57355016,"about_ca_system_score_codex":0.000059682174,"about_ca_system_score_gemma":0.00012784277,"threshold_uncertainty_score":0.6162677},"labels":[],"label_agreement":null},{"id":"W4417153287","doi":"10.1080/19420862.2025.2599580","title":"Functional NK engagers from OmniClic, a common light-chain platform producing fully human-sequence antibodies in a chicken host species","year":2025,"lang":"en","type":"article","venue":"mAbs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia; OmniActive Health Technologies (Canada)","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Epitope; Antibody; Epitope mapping; Immune system; Antigen; Functional diversity; Host (biology); Linear epitope","score_opus":0.06410342842464639,"score_gpt":0.33183049261380665,"score_spread":0.26772706418916026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417153287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95633936,0.0012531186,0.00001866729,0.011743765,0.00024369887,0.00044700323,0.00005831654,0.000072683615,0.029823389],"genre_scores_gemma":[0.96615404,0.00023801932,0.00020434707,0.00084046804,0.00033462472,0.000039572227,0.00021332655,0.00001768088,0.031957895],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980829,0.0000675646,0.0004348187,0.000507177,0.00043902002,0.0004685394],"domain_scores_gemma":[0.9990652,0.00026734968,0.000068539186,0.0003812143,0.00010613058,0.00011154194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046714055,0.0002467081,0.00047096593,0.00037470536,0.00033858448,0.000060972136,0.00019766744,0.000120159646,0.00074326113],"category_scores_gemma":[0.00020548697,0.0002006549,0.00013305296,0.00042212688,0.0002029546,0.00013351323,0.00021606212,0.0007550929,0.0001074347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017006892,0.00038572014,0.46322834,0.00046609764,0.00024526098,0.00036867117,0.0022836537,0.000016624115,0.4997668,0.010696757,0.017752623,0.0030887844],"study_design_scores_gemma":[0.0015436538,0.00022358882,0.929069,0.0009281461,0.00003890254,0.000024796302,0.000904638,0.00023124357,0.027390659,0.001913865,0.03745229,0.000279259],"about_ca_topic_score_codex":0.0022065807,"about_ca_topic_score_gemma":0.0019304574,"teacher_disagreement_score":0.4723761,"about_ca_system_score_codex":0.00013081939,"about_ca_system_score_gemma":0.00017551507,"threshold_uncertainty_score":0.8182469},"labels":[],"label_agreement":null}]}